Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
ACTN2,Alpha-actinin-2,Lifestyle factors,X1050.Time spend outdoors in summer,45047,-0.0077252741081249,0.0233565226536221,-0.0535040585092242,0.0380535102929745,0.740833324776352
ACTN2,Alpha-actinin-2,Lifestyle factors,X1060.Time spent outdoors in winter,41927,0.0815578260055933,0.0268936807573229,0.0288462117212405,0.134269440289946,0.00242810813761901
ACTN2,Alpha-actinin-2,Physical activities,X1070.Time spent watching television (TV),46347,-0.121894789911939,0.0237904542285987,-0.168524080199992,-0.0752654996238857,3.02165243487978e-07
ACTN2,Alpha-actinin-2,Physical activities,X1080.Time spent using computer,41893,-0.0857502666004987,0.0255236438251681,-0.135776608497828,-0.0357239247031692,0.000782112221104502
ACTN2,Alpha-actinin-2,Physical activities,X1090.Time spent driving,39712,-0.0505981574911346,0.0279841616666436,-0.105447114357756,0.00425079937548681,0.0706106472244793
ACTN2,Alpha-actinin-2,Lifestyle factors,X1160.Sleep duration,47633,-0.0846155463500487,0.0216638008426147,-0.127076596001574,-0.0421544966985238,9.41611178901249e-05
ACTN2,Alpha-actinin-2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32384,0.0147432767883804,0.0212927141323535,-0.0269904429110324,0.0564769964877932,0.488700493137926
ACTN2,Alpha-actinin-2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32384,-0.0183957073898532,0.0190026636704692,-0.0556409281839729,0.0188495134042665,0.333044215116905
ACTN2,Alpha-actinin-2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32384,0.0174739138160238,0.0223822834116264,-0.0263953616707639,0.0613431893028116,0.435000545688541
ACTN2,Alpha-actinin-2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32384,0.0352632380394695,0.0228380490001848,-0.00949933800089262,0.0800258140798316,0.12261453801064
ACTN2,Alpha-actinin-2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32384,0.010491895461675,0.0231896859320141,-0.0349598889650726,0.0559436798884227,0.65096583937232
ACTN2,Alpha-actinin-2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32384,-0.0223625418627349,0.0445220960256165,-0.109625850072943,0.0649007663474735,0.615484779753078
ACTN2,Alpha-actinin-2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32384,0.0162354004243953,0.0437417526534896,-0.0694984347764443,0.101969235625235,0.710524675383003
ACTN2,Alpha-actinin-2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32384,0.0170821882984938,0.0342978654943027,-0.0501416280703394,0.084306004667327,0.618459806297317
ACTN2,Alpha-actinin-2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32384,-0.0148044607117053,0.0244929175823464,-0.0628105791731042,0.0332016577496935,0.545569478675978
ACTN2,Alpha-actinin-2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32384,0.00336874665038032,0.0170643789126823,-0.030077436018477,0.0368149293192376,0.843508662865293
ACTN2,Alpha-actinin-2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32384,-0.00111897350313478,0.0236114624864306,-0.0473974399765387,0.0451594929702691,0.962202704402778
ACTN2,Alpha-actinin-2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32384,0.0140354346226362,0.0144678798060205,-0.0143216097971639,0.0423924790424364,0.332021253616278
ACTN2,Alpha-actinin-2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32384,-0.00753084817187198,0.0180533089531227,-0.0429153337199925,0.0278536373762485,0.676583616199061
ACTN2,Alpha-actinin-2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32384,-0.0118263870354833,0.0256796246916589,-0.0621584514311348,0.0385056773601683,0.645144291191396
ACTN2,Alpha-actinin-2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32384,-0.0301953616413688,0.0242845512927302,-0.0777930821751199,0.0174023588923824,0.21375796859581
ACTN2,Alpha-actinin-2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32384,-0.0106543176971536,0.0337824416456147,-0.0768679033225584,0.0555592679282512,0.752481194177538
ACTN2,Alpha-actinin-2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32384,-0.0658076329602517,0.0321307907370656,-0.1287839828049,-0.0028312831156032,0.040581345522342
ACTN2,Alpha-actinin-2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32384,0.00292144072631584,0.0191771048049116,-0.0346656846913109,0.0405085661439426,0.878922628388435
ACTN2,Alpha-actinin-2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32384,0.00875767660530143,0.0178982267246762,-0.026322847775064,0.0438382009856668,0.624639913740274
ACTN2,Alpha-actinin-2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32384,0.0310773451388423,0.0237202940328638,-0.0154144311655708,0.0775691214432555,0.190180156214498
ACTN2,Alpha-actinin-2,Health and medical history,X120040.Fatigue severity over the past week,32391,0.0372612719306574,0.0373903261008997,-0.036023767227106,0.110546311088421,0.319014113348694
ACTN2,Alpha-actinin-2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32390,0.0540839342922932,0.0371571143049512,-0.0187440097454111,0.126911878329998,0.145557383794985
ACTN2,Alpha-actinin-2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32388,0.0775185141508988,0.0401128819892952,-0.00110273454811978,0.156139762849917,0.0533322367102454
ACTN2,Alpha-actinin-2,Health and medical history,X120098.Mobility problems today,32394,0.110007277443124,0.0431062756203737,0.0255189772271911,0.194495577659056,0.0107291739060833
ACTN2,Alpha-actinin-2,Health and medical history,X120099.Self-care problems today,32394,0.0273203702494592,0.0676177111148654,-0.105210343535677,0.159851084034595,0.686192989351855
ACTN2,Alpha-actinin-2,Health and medical history,X120100.Problems doing usual activities,32394,0.0742900004380243,0.0412488657460482,-0.00655777642423012,0.155137777300279,0.0717377827085988
ACTN2,Alpha-actinin-2,Health and medical history,X120101.Pain or discomfort today,32394,0.0097693435824313,0.0379320222221289,-0.0645774199729413,0.0841161071378039,0.796761889114524
ACTN2,Alpha-actinin-2,Health and medical history,X120102.Anxiety or depression today,32394,0.015576476078677,0.0436932923715929,-0.0700623769696452,0.101215329126999,0.721478755905168
ACTN2,Alpha-actinin-2,Health and medical history,X120103.Scale to indicate how health is today,32357,-0.00829285401837811,0.00626437379822737,-0.0205710266629038,0.00398531862614753,0.185603726407196
ACTN2,Alpha-actinin-2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32369,0.0928785138740392,0.0445211433101461,0.00561707298615281,0.180139954761926,0.0369954885379807
ACTN2,Alpha-actinin-2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32347,0.043304273055487,0.0453475221818305,-0.0455768704209008,0.132185416531875,0.339636055748193
ACTN2,Alpha-actinin-2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32377,0.0448367920557665,0.036959424088969,-0.0276036791586128,0.117277263270146,0.225114158453983
ACTN2,Alpha-actinin-2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32378,0.0396124257826914,0.0379618986110985,-0.0347928954950617,0.114017747060445,0.296758556601526
ACTN2,Alpha-actinin-2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32379,0.0882237770218592,0.0453220680804604,-0.000607476415843189,0.177055030459562,0.0516184214809648
ACTN2,Alpha-actinin-2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32354,0.0526180720419834,0.0473630294006767,-0.0402134655833429,0.14544960966731,0.26662264146629
ACTN2,Alpha-actinin-2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32376,0.0365465995924798,0.0489274459105396,-0.0593511943921777,0.132444393577137,0.455112901952248
ACTN2,Alpha-actinin-2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32368,0.0232188566748088,0.0711452813047501,-0.116225894682501,0.162663608032119,0.744161874877707
ACTN2,Alpha-actinin-2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32336,-0.0769145410744607,0.10101939943271,-0.274912563962572,0.121083481813651,0.446450598920349
ACTN2,Alpha-actinin-2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30420,0.0469334127120609,0.0480385407865895,-0.0472221272296544,0.141088952653776,0.328611255806368
ACTN2,Alpha-actinin-2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45631,-0.0388300811003877,0.0536610009368831,-0.144005642936679,0.0663454807359032,0.469308109152728
ACTN2,Alpha-actinin-2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,44046,-0.0500191112327176,0.0345919897432234,-0.117819411129435,0.0177811886640001,0.148200542769826
ACTN2,Alpha-actinin-2,Diet and food preferences,X1289.Cooked vegetable intake,47181,0.0444575605950568,0.0226462249118115,7.09597679063451e-05,0.0888441614222072,0.0496428510424704
ACTN2,Alpha-actinin-2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46762,0.0841245129030663,0.024869694250462,0.0353799121721607,0.132869113633972,0.000719234903547206
ACTN2,Alpha-actinin-2,Diet and food preferences,X1309.Fresh fruit intake,47235,0.151936511856651,0.0235120188204478,0.105852954968573,0.198020068744729,1.0536270964137e-10
ACTN2,Alpha-actinin-2,Diet and food preferences,X1319.Dried fruit intake,45769,0.0639936047593211,0.0236358171087971,0.0176674032260789,0.110319806292563,0.00678493061487875
ACTN2,Alpha-actinin-2,Health and medical history,X134.Number of self-reported cancers,47887,-0.00207561532016653,0.0389894922670787,-0.0784950201636408,0.0743437895233078,0.957544924784668
ACTN2,Alpha-actinin-2,Health and medical history,X135.Number of self-reported non-cancer illnesses,47887,0.0511555785713831,0.0226898300877895,0.00668351159931569,0.0956276455434505,0.0241701670308743
ACTN2,Alpha-actinin-2,Health and medical history,"X136.Number of operations, self-reported",47887,0.0398821692524131,0.022847943236682,-0.00489979949148369,0.0846641379963099,0.0809027245632697
ACTN2,Alpha-actinin-2,Health and medical history,X137.Number of treatments or medications taken,47887,0.0727429762828473,0.022155017659136,0.0293191416709407,0.116166810894754,0.00102726536604853
ACTN2,Alpha-actinin-2,Diet and food preferences,X1438.Bread intake,47071,0.00128287168979138,0.0040547924557291,-0.00666452152343766,0.00923026490302043,0.751713935709026
ACTN2,Alpha-actinin-2,Diet and food preferences,X1458.Cereal intake,46690,0.0731571718698671,0.022374422976729,0.0293033028354783,0.117011040904256,0.00107833378517743
ACTN2,Alpha-actinin-2,Diet and food preferences,X1488.Tea intake,47093,0.0115319567336122,0.0037623537697959,0.00415774334481225,0.0189061701224122,0.00217859820479708
ACTN2,Alpha-actinin-2,Diet and food preferences,X1498.Coffee intake,46046,0.00776782030856995,0.0225502159870604,-0.0364306030260685,0.0519662436432084,0.730497961899794
ACTN2,Alpha-actinin-2,Diet and food preferences,X1528.Water intake,46431,0.0875076491158137,0.0233804269176587,0.0416820123572026,0.133333285874425,0.000182463414038843
ACTN2,Alpha-actinin-2,Lifestyle factors,X1568.Average weekly red wine intake,38735,-0.00833727212966576,0.0278347611270125,-0.0628934039386102,0.0462188596792787,0.764542068731669
ACTN2,Alpha-actinin-2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,38730,-0.0191929353857193,0.0278820533548196,-0.0738417599611658,0.0354558891897271,0.491236271619214
ACTN2,Alpha-actinin-2,Lifestyle factors,X1588.Average weekly beer plus cider intake,38756,-0.0614968138044262,0.0355695072194056,-0.131213047954461,0.00821942034560883,0.083845086203242
ACTN2,Alpha-actinin-2,Lifestyle factors,X1598.Average weekly spirits intake,38693,0.0232618663547301,0.0314163901337339,-0.0383142583073884,0.0848379910168485,0.459046915061846
ACTN2,Alpha-actinin-2,Lifestyle factors,X1608.Average weekly fortified wine intake,38763,0.0605225869746059,0.0477224668815489,-0.0330134481132299,0.154058622062442,0.204740028545442
ACTN2,Alpha-actinin-2,Lifestyle factors,X1737.Childhood sunburn occasions,42300,-0.0380115945701073,0.0270859137306427,-0.091099985482167,0.0150767963419524,0.160523537904989
ACTN2,Alpha-actinin-2,Health and medical history,X1807.Father's age at death,41635,0.000134820179499586,0.00429346150357343,-0.00828036436750433,0.0085500047265035,0.974949886430462
ACTN2,Alpha-actinin-2,Health and medical history,X1845.Mother's age,33545,0.00961967028048043,0.0101716787986663,-0.0103168201649055,0.0295561607258663,0.344311020603973
ACTN2,Alpha-actinin-2,Health and medical history,X1873.Number of full brothers,47447,0.00452456478737476,0.0217770213772516,-0.0381583971120383,0.0472075266867878,0.835412081232993
ACTN2,Alpha-actinin-2,Health and medical history,X1883.Number of full sisters,47450,-0.0130889930816514,0.0217793242538814,-0.0557764686192588,0.0295984824559561,0.547857554888831
ACTN2,Alpha-actinin-2,Physical measures,X20015.Sitting height,47728,0.00934222359188746,0.00496494108541006,-0.000389060935516255,0.0190735081192912,0.0598976024648997
ACTN2,Alpha-actinin-2,Cognitive function,X20016.Fluid intelligence score,32059,-0.0268126488339526,0.034553811812184,-0.0945381199858333,0.040912822317928,0.437792100500825
ACTN2,Alpha-actinin-2,Cognitive function,X20018.Prospective memory result,32341,-0.036775457666633,0.0457844299297265,-0.126512940328897,0.0529620249956311,0.421865632199387
ACTN2,Alpha-actinin-2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31952,0.00338598113546742,0.00712543557314213,-0.0105798725878912,0.017351834858826,0.634660850526182
ACTN2,Alpha-actinin-2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31932,-0.000436893445233087,0.00715426952175025,-0.0144592617078636,0.0135854748173974,0.951307073418724
ACTN2,Alpha-actinin-2,Cognitive function,X20023.Mean time to correctly identify matches,47606,0.00400600159662479,0.00408104953474922,-0.00399285549148368,0.0120048586847332,0.326301966057415
ACTN2,Alpha-actinin-2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45149,-0.01303668124542,0.00835112792834223,-0.0294048919849708,0.00333152949413074,0.118522921227832
ACTN2,Alpha-actinin-2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44794,0.00411324069567929,0.0180861906172156,-0.0313356929140632,0.0395621743054218,0.820096049621537
ACTN2,Alpha-actinin-2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44765,-0.008526930652504,0.0246691955237167,-0.0568785538789888,0.0398246925739808,0.729608636746379
ACTN2,Alpha-actinin-2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44781,-0.0226697066485795,0.0194906704302044,-0.0608714206917802,0.0155320073946211,0.244800339179207
ACTN2,Alpha-actinin-2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44788,0.0163554086445957,0.0147964792945773,-0.0126456907727757,0.0453565080619672,0.26901751690948
ACTN2,Alpha-actinin-2,Health and medical history,X20107#2.Illnesses of father_Stroke,44916,0.00134761599557899,0.0108799086750574,-0.0199770050075336,0.0226722369986915,0.901425120708328
ACTN2,Alpha-actinin-2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44873,-0.00466239464908824,0.0135581174400813,-0.0312363048316475,0.021911515533471,0.730938452833752
ACTN2,Alpha-actinin-2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44791,-0.01323954397654,0.0173332005706429,-0.0472126170950001,0.0207335291419201,0.444979982508869
ACTN2,Alpha-actinin-2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44925,0.00153715485062401,0.01221945785549,-0.0224129825461365,0.0254872922473845,0.899894907024009
ACTN2,Alpha-actinin-2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44963,0.00791244941633822,0.00930415211971199,-0.0103236887382973,0.0261485875709737,0.395100808678548
ACTN2,Alpha-actinin-2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44853,0.0302036998352881,0.0129685345518138,0.00478537211373317,0.0556220275568431,0.0198688496357491
ACTN2,Alpha-actinin-2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46307,-0.000247619690812126,0.00928099536085911,-0.018438370598096,0.0179431312164717,0.978714973730994
ACTN2,Alpha-actinin-2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46195,-0.0229258988001434,0.0136186981374143,-0.0496185471494755,0.00376674954918874,0.0923094484570696
ACTN2,Alpha-actinin-2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46138,-0.0101226884227177,0.0290447125235275,-0.0670503249688316,0.0468049481233962,0.727452427828846
ACTN2,Alpha-actinin-2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46168,0.00156958030161945,0.0146173533897696,-0.0270804323423289,0.0302195929455678,0.91449020051013
ACTN2,Alpha-actinin-2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46254,7.10719754263399e-05,0.0106543230186195,-0.020811401141068,0.0209535450919206,0.994677638271844
ACTN2,Alpha-actinin-2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46151,-0.0232717529604539,0.0198319669340219,-0.0621424081511368,0.0155989022302289,0.240629663661284
ACTN2,Alpha-actinin-2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46148,-0.00979692268349656,0.017550338060232,-0.0441955852815513,0.0246017399145582,0.576700977128445
ACTN2,Alpha-actinin-2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46177,0.0156747033694365,0.0138149230952842,-0.0114025458973207,0.0427519526361936,0.25654662309172
ACTN2,Alpha-actinin-2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46195,-0.00691662104991611,0.0156443573662812,-0.0375795614878273,0.023746319387995,0.658409648035504
ACTN2,Alpha-actinin-2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46335,-0.00946666497429093,0.0080493645101602,-0.0252434194142049,0.00631008946562306,0.23957727375127
ACTN2,Alpha-actinin-2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46208,-0.00535509442782698,0.0126694452370353,-0.0301872070924162,0.0194770182367622,0.672534463827181
ACTN2,Alpha-actinin-2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43282,0.00719533386185459,0.0131091459572658,-0.0184985922143865,0.0328892599380956,0.58309505424839
ACTN2,Alpha-actinin-2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43155,0.0261938116747493,0.0515059643920082,-0.0747578785335869,0.127145501883085,0.611067509287806
ACTN2,Alpha-actinin-2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43151,0.000701670444180518,0.0537642466207302,-0.104676252932451,0.106079593820812,0.98958734342418
ACTN2,Alpha-actinin-2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43211,0.00161185381867438,0.0147033541137677,-0.0272067202443102,0.030430427881659,0.912708029855756
ACTN2,Alpha-actinin-2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43165,0.0654952783095638,0.0310621669404285,0.00461343110632392,0.126377125512804,0.0349990728416609
ACTN2,Alpha-actinin-2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43181,0.0142047860550893,0.0222277371056072,-0.0293615786719008,0.0577711507820794,0.522793811487919
ACTN2,Alpha-actinin-2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43160,0.0303364923669439,0.0270435137790998,-0.0226687946400916,0.0833417793739794,0.261976373746275
ACTN2,Alpha-actinin-2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43159,0.000477143602957622,0.0265950804020869,-0.0516492139851328,0.052603501191048,0.985686074374166
ACTN2,Alpha-actinin-2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43174,-0.00823639809717709,0.0191203963114879,-0.0457123748676933,0.0292395786733391,0.666644187895961
ACTN2,Alpha-actinin-2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43182,-0.000305852364094882,0.0236109197686371,-0.0465832551106237,0.0459715503824339,0.989664748374908
ACTN2,Alpha-actinin-2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43336,-0.0136669705822517,0.00968994622334295,-0.0326592651800039,0.00532532401550049,0.15842984093236
ACTN2,Alpha-actinin-2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43235,0.0184247425397538,0.0138825310881099,-0.00878501839294164,0.0456345034724493,0.184462302439764
ACTN2,Alpha-actinin-2,Mental health,X20127.Neuroticism score,42877,-0.00842378896103052,0.0225570061151728,-0.0526355209467692,0.0357879430247081,0.708821973873028
ACTN2,Alpha-actinin-2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32059,-0.0311284573804816,0.0352362641018412,-0.10019153502009,0.0379346202591271,0.377036780455066
ACTN2,Alpha-actinin-2,Lifestyle factors,X20161.Pack years of smoking,30742,-0.00924993891768174,0.00793015462150171,-0.0247930419758251,0.0062931641404616,0.243486447277621
ACTN2,Alpha-actinin-2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30742,-0.00896195720795971,0.00781884676440117,-0.024286896866186,0.00636298245026658,0.251756265371586
ACTN2,Alpha-actinin-2,Cognitive function,X20191.Fluid intelligence score,30287,-0.0132168372315628,0.0400220245471172,-0.0916600053439124,0.0652263308807869,0.741231187726038
ACTN2,Alpha-actinin-2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30287,-0.00578781663657706,0.0409172349504876,-0.0859855971395328,0.0744099638663787,0.887517926336977
ACTN2,Alpha-actinin-2,Cognitive function,X20240.Maximum digits remembered correctly,29648,0.0141539096291713,0.0433961835327124,-0.0709026100949451,0.0992104293532877,0.744319763827607
ACTN2,Alpha-actinin-2,Physical measures,X20255.Spirometry QC measure,42398,-0.0159577768876426,0.0306179134773571,-0.0759688873032625,0.0440533335279772,0.602240245745998
ACTN2,Alpha-actinin-2,Eye measures,X20261.avMSE,29628,-0.00123471824293947,0.00821392156566222,-0.0173340045116374,0.0148645680257585,0.880517862570554
ACTN2,Alpha-actinin-2,Eye measures,X20262.Myopia diagnosis,29628,-0.00570613809463031,0.0515954547121784,-0.1068332293305,0.0954209531412395,0.911942742104488
ACTN2,Alpha-actinin-2,NMR metabolomics,X20280.Glucose-lactate,37529,-0.00515643994435724,0.00523950627101933,-0.0154258722355551,0.00511299234684065,0.325061864175537
ACTN2,Alpha-actinin-2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37555,-0.0420555111846641,0.00499959121776453,-0.0518547099714826,-0.0322563123978456,4.45314360005622e-17
ACTN2,Alpha-actinin-2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31806,0.0297284697864029,0.0232594323531579,-0.0158600176257866,0.0753169571985924,0.201245576602042
ACTN2,Alpha-actinin-2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31804,0.0562820923931135,0.0444061286314792,-0.0307539197245858,0.143318104510813,0.205038237811597
ACTN2,Alpha-actinin-2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31802,-0.00540121758142218,0.0556141384024552,-0.114404928850234,0.10360249368739,0.922634139509553
ACTN2,Alpha-actinin-2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31802,0.00719709780510967,0.0219222782116628,-0.0357705674897495,0.0501647630999689,0.742693717941449
ACTN2,Alpha-actinin-2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31802,0.0221848589083757,0.0439252972463676,-0.0639087236945048,0.108278441511256,0.613532664597569
ACTN2,Alpha-actinin-2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31808,0.024435814042458,0.0519917967159415,-0.0774681075207874,0.126339735605703,0.638373490613368
ACTN2,Alpha-actinin-2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31808,-0.0202500652620844,0.0353532329587025,-0.0895424018611414,0.0490422713369725,0.566802732090642
ACTN2,Alpha-actinin-2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31808,-0.0226873688627786,0.038707596283241,-0.0985542575779309,0.0531795198523737,0.557811601215587
ACTN2,Alpha-actinin-2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31808,0.00336752126670918,0.0630486415366072,-0.120207816145041,0.126942858678459,0.957405508808299
ACTN2,Alpha-actinin-2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31808,-0.0154930563888059,0.0754464415998045,-0.163368081924423,0.132381969146811,0.837303022030676
ACTN2,Alpha-actinin-2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31808,-0.0527984101635726,0.0403126469378656,-0.131811198161789,0.0262143778346439,0.190330383895021
ACTN2,Alpha-actinin-2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31808,-0.0243356597842624,0.0768776566961771,-0.17501586690877,0.126344547340245,0.751593691732188
ACTN2,Alpha-actinin-2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31808,-0.0191661375651376,0.0528636625965769,-0.122778916254428,0.0844466411241532,0.716945593339363
ACTN2,Alpha-actinin-2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31808,0.0297239771058202,0.065095470576018,-0.097863145223175,0.157311099434815,0.647956763086419
ACTN2,Alpha-actinin-2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31808,0.0427564042882414,0.0297527922108109,-0.0155590684449479,0.101071877021431,0.150744845407753
ACTN2,Alpha-actinin-2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31808,0.0395771972989796,0.0490564557925063,-0.0565734560543327,0.135727850652292,0.419826023219695
ACTN2,Alpha-actinin-2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31809,0.0147117629499307,0.0723687854483263,-0.127131056528789,0.15655458242865,0.838914937654577
ACTN2,Alpha-actinin-2,Diet and food preferences,X20600.Liking for adding salt to foods,33160,-0.0272588222044554,0.0332252697660693,-0.0923803509459512,0.0378627065370404,0.411996687236271
ACTN2,Alpha-actinin-2,Diet and food preferences,X20601.Liking for aniseed,33160,-0.0342177106275911,0.0331625890820938,-0.0992163852284949,0.0307809639733128,0.302186716635788
ACTN2,Alpha-actinin-2,Diet and food preferences,X20602.Liking for apple juice,33160,0.0435100653092568,0.0327566865686388,-0.0206930403652752,0.107713170983789,0.184120332901929
ACTN2,Alpha-actinin-2,Diet and food preferences,X20603.Liking for apples,33160,0.0652142981387367,0.034311998945642,-0.00203721979472173,0.132465816072195,0.0573839617068394
ACTN2,Alpha-actinin-2,Diet and food preferences,X20604.Liking for asparagus,33160,-0.00719836506381884,0.0339466949859113,-0.073733887236205,0.0593371571085673,0.832073721167279
ACTN2,Alpha-actinin-2,Diet and food preferences,X20605.Liking for aubergine,33160,-0.00443271769781674,0.0333136067757443,-0.0697273869782756,0.0608619515826422,0.894148788954178
ACTN2,Alpha-actinin-2,Diet and food preferences,X20606.Liking for avocados,33160,-0.0169894327842469,0.0341552012721629,-0.0839336272776863,0.0499547617091924,0.618906456096932
ACTN2,Alpha-actinin-2,Diet and food preferences,X20607.Liking for bacon,33160,-0.0491571271434217,0.0333123084159001,-0.114449251638586,0.0161349973517426,0.140075525810417
ACTN2,Alpha-actinin-2,Diet and food preferences,X20608.Liking for baked or steamed fish,33160,0.037023715491156,0.0343337136932588,-0.0302703633476313,0.104317794329943,0.280908072032535
ACTN2,Alpha-actinin-2,Diet and food preferences,X20609.Liking for bananas,33160,0.060187354567473,0.0346782724970817,-0.00778205952680709,0.128156768661753,0.08267129924949
ACTN2,Alpha-actinin-2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33160,-0.0196373524190367,0.0331618826311019,-0.0846346423759964,0.0453599375379231,0.553754561785824
ACTN2,Alpha-actinin-2,Diet and food preferences,X20611.Liking for beef steak,33160,-0.0173667025445769,0.0333628750878242,-0.0827579377167124,0.0480245326275587,0.602700680601351
ACTN2,Alpha-actinin-2,Diet and food preferences,X20612.Liking for beetroot,33160,-0.0321940150145519,0.0342115486184406,-0.0992486503066953,0.0348606202775916,0.346716792938598
ACTN2,Alpha-actinin-2,Diet and food preferences,X20613.Liking for bell pepper,33160,0.0246602544182819,0.0332288630360928,-0.0404683171324599,0.0897888259690237,0.458026455247924
ACTN2,Alpha-actinin-2,Diet and food preferences,X20614.Liking for bicycling,33160,0.046669875587355,0.0332007503898822,-0.0184035951768141,0.111743346351524,0.159852692366984
ACTN2,Alpha-actinin-2,Diet and food preferences,X20615.Liking for biscuits,33160,-0.0265166661126324,0.0332469813060153,-0.0916807494724223,0.0386474172471575,0.425144084020509
ACTN2,Alpha-actinin-2,Diet and food preferences,X20616.Liking for bitter foods,33160,-0.0202771644485309,0.0330965412788601,-0.0851463853550966,0.0445920564580348,0.540112446405346
ACTN2,Alpha-actinin-2,Diet and food preferences,X20617.Liking for bitter or ale,33160,-0.00625829114267655,0.0343808262400708,-0.0736447105732153,0.0611281282878622,0.855564580276727
ACTN2,Alpha-actinin-2,Diet and food preferences,X20618.Liking for black olives,33160,0.00228692284871505,0.0333459428562945,-0.0630711251496222,0.0676449708470523,0.94532412870658
ACTN2,Alpha-actinin-2,Diet and food preferences,X20619.Liking for black pepper,33160,-0.0135177403003527,0.0338188399715129,-0.079802666644518,0.0527671860438126,0.68937968293188
ACTN2,Alpha-actinin-2,Diet and food preferences,X20620.Liking for blue cheese,33160,0.00284038917797674,0.0329121160656235,-0.0616673583106454,0.0673481366665988,0.931228148003637
ACTN2,Alpha-actinin-2,Diet and food preferences,X20621.Liking for bolognese sauce,33160,-0.0208320926052851,0.033307171978372,-0.0861141496828943,0.044449964472324,0.531689760889805
ACTN2,Alpha-actinin-2,Diet and food preferences,X20622.Liking for broad beans,33160,0.0526687279133681,0.0333169086558142,-0.0126324130520278,0.117969868878764,0.113950803575936
ACTN2,Alpha-actinin-2,Diet and food preferences,X20623.Liking for broccoli,33160,0.0579431547625807,0.0347743216504146,-0.010214515672232,0.126100825197393,0.0956971072624261
ACTN2,Alpha-actinin-2,Diet and food preferences,X20624.Liking for brown rice,33160,0.0484617866077002,0.0336308227699809,-0.0174546260214624,0.114378199236863,0.149622599271241
ACTN2,Alpha-actinin-2,Diet and food preferences,X20625.Liking for brussel sprouts,33160,0.0251799813030248,0.0337132483192937,-0.0408979854027908,0.0912579480088404,0.45515205969917
ACTN2,Alpha-actinin-2,Diet and food preferences,X20626.Liking for burgers (meat),33160,-0.0452096342489753,0.0332891414569135,-0.110456351504526,0.0200370830065752,0.174470500905562
ACTN2,Alpha-actinin-2,Diet and food preferences,X20627.Liking for burn of spicy foods,33160,-0.0476907719059273,0.0330439120889974,-0.112456839600362,0.0170752957885076,0.148984824850064
ACTN2,Alpha-actinin-2,Diet and food preferences,X20628.Liking for butter on bread,33160,0.0106977709242093,0.0339705065950867,-0.0558844220021607,0.0772799638505793,0.752834888897266
ACTN2,Alpha-actinin-2,Diet and food preferences,X20629.Liking for butternut squash,33160,0.0518682427612215,0.0333236183110225,-0.0134460491283827,0.117182534650826,0.119625400596302
ACTN2,Alpha-actinin-2,Diet and food preferences,X20630.Liking for cabbage,33160,0.00849231391353179,0.0336110243326518,-0.0573852937784658,0.0743699216055294,0.800533423768182
ACTN2,Alpha-actinin-2,Diet and food preferences,X20631.Liking for cake,33160,-0.0265479259504215,0.0336761923929928,-0.0925532630406874,0.0394574111398444,0.430525651055822
ACTN2,Alpha-actinin-2,Diet and food preferences,X20632.Liking for cake icing,33160,0.0381840837400559,0.0327828424915868,-0.0260702875434542,0.102438455023566,0.244148833952722
ACTN2,Alpha-actinin-2,Diet and food preferences,X20633.Liking for capers,33160,-0.0122668167407532,0.0331022800117215,-0.0771472855637274,0.052613652082221,0.710964493679776
ACTN2,Alpha-actinin-2,Diet and food preferences,X20634.Liking for cauliflower,33160,0.00721332923076662,0.0343155803725406,-0.0600452082994129,0.0744718667609462,0.833512085001722
ACTN2,Alpha-actinin-2,Diet and food preferences,X20635.Liking for cereal or granola bar,33160,-0.00345001950858986,0.0330338723065308,-0.0681964092293902,0.0612963702122104,0.916823504168562
ACTN2,Alpha-actinin-2,Diet and food preferences,X20636.Liking for cheesecake,33160,-0.0230152404304572,0.0330168152969019,-0.0877281984123849,0.0416977175514705,0.48577365425051
ACTN2,Alpha-actinin-2,Diet and food preferences,X20637.Liking for cherries,33160,0.036539232230916,0.036524987443724,-0.0350497431587829,0.108128207620615,0.31714963291447
ACTN2,Alpha-actinin-2,Diet and food preferences,X20638.Liking for chicken,33160,-0.0141187705312034,0.0351239703877517,-0.0829617524911968,0.05472421142879,0.687716228609176
ACTN2,Alpha-actinin-2,Diet and food preferences,X20639.Liking for chilli pepper,33160,-0.0465689065463977,0.0333248810761496,-0.111885673455651,0.0187478603628555,0.162322484490592
ACTN2,Alpha-actinin-2,Diet and food preferences,X20640.Liking for chips or french fries,33160,-0.10117189816643,0.0334660834216099,-0.166765421672785,-0.0355783746600742,0.0025091405805867
ACTN2,Alpha-actinin-2,Diet and food preferences,X20641.Liking for cigarette smoking,33160,-0.0402381503333442,0.0554712823923925,-0.148961863822433,0.0684855631557451,0.468234123311981
ACTN2,Alpha-actinin-2,Diet and food preferences,X20642.Liking for cod,33160,-0.0131803418344527,0.0345966875094509,-0.0809898493529765,0.0546291656840711,0.703233916334811
ACTN2,Alpha-actinin-2,Diet and food preferences,X20643.Liking for coffee with sugar,33160,-0.0151080168179237,0.0379537440650492,-0.0894973551854202,0.0592813215495728,0.690592824457437
ACTN2,Alpha-actinin-2,Diet and food preferences,X20644.Liking for coffee without sugar,33160,0.00274791763525072,0.0341626615514165,-0.0642108990055257,0.0697067342760271,0.935892118207148
ACTN2,Alpha-actinin-2,Diet and food preferences,X20645.Liking for coriander,33160,0.0392947559208205,0.0331701215308109,-0.0257186822795688,0.10430819412121,0.236190948969731
ACTN2,Alpha-actinin-2,Diet and food preferences,X20646.Liking for corn flakes,33160,-0.062019248890748,0.0327008785405454,-0.126112970830217,0.00207447304872101,0.0579188458461435
ACTN2,Alpha-actinin-2,Diet and food preferences,X20647.Liking for cream,33160,0.0587733029355804,0.0333159350542061,-0.00652592977066356,0.124072535641824,0.0777468930341449
ACTN2,Alpha-actinin-2,Diet and food preferences,X20648.Liking for croissant,33160,-0.0188391044220313,0.0329584020459709,-0.0834375724321343,0.0457593635880717,0.567606081677283
ACTN2,Alpha-actinin-2,Diet and food preferences,X20649.Liking for cucumber,33160,-0.0331527584453161,0.0339556699428687,-0.0997058715333388,0.0334003546427065,0.328916156135346
ACTN2,Alpha-actinin-2,Diet and food preferences,X20650.Liking for curry,33160,-0.0154321133014552,0.0335189217020692,-0.0811291998375109,0.0502649732346004,0.645240605269315
ACTN2,Alpha-actinin-2,Diet and food preferences,X20651.Liking for dairy products,33160,0.0959732007077826,0.0340378571154212,0.0292590007615572,0.162687400654008,0.00481920082525748
ACTN2,Alpha-actinin-2,Diet and food preferences,X20652.Liking for dark chocolate,33160,0.0314541171399203,0.033461800626508,-0.0341310120880354,0.0970392463678761,0.34724328456336
ACTN2,Alpha-actinin-2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33160,-0.0697746474107463,0.0349967244055961,-0.138368227245715,-0.00118106757577793,0.0462107764746731
ACTN2,Alpha-actinin-2,Diet and food preferences,X20654.Liking for dried fruit,33160,0.0451474121130736,0.033178343085123,-0.0198821403337676,0.110176964559915,0.17362813424125
ACTN2,Alpha-actinin-2,Diet and food preferences,X20655.Liking for eggs,33160,0.0135437669661157,0.0347081466665505,-0.0544842005003233,0.0815717344325547,0.696384408575366
ACTN2,Alpha-actinin-2,Diet and food preferences,X20656.Liking for exercising alone,33160,0.125367573324447,0.0334621880479665,0.0597816847504329,0.190953461898461,0.000180446403994087
ACTN2,Alpha-actinin-2,Diet and food preferences,X20657.Liking for exercising with others,33160,0.0536238367855035,0.0334748388680012,-0.0119868473957789,0.119234520966786,0.109210780109493
ACTN2,Alpha-actinin-2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33160,-0.0116741928410028,0.0340964174829095,-0.0785031711075056,0.0551547854254999,0.732067440403775
ACTN2,Alpha-actinin-2,Diet and food preferences,X20659.Liking for fatty foods,33160,0.00108646850947059,0.0331721414175438,-0.0639309286689152,0.0661038656878564,0.973872758132722
ACTN2,Alpha-actinin-2,Diet and food preferences,X20660.Liking for fresh tomatoes,33160,-0.00181643213932693,0.0370794836855212,-0.0744922201629486,0.0708593558842947,0.960930362128602
ACTN2,Alpha-actinin-2,Diet and food preferences,X20661.Liking for fried chicken,33160,-0.0918035863572317,0.0329340782749803,-0.156354379776193,-0.0272527929382702,0.00532324720270392
ACTN2,Alpha-actinin-2,Diet and food preferences,X20662.Liking for fried or battered fish,33160,-0.0457716446844319,0.0332666450103993,-0.110974268904814,0.0194309795359507,0.168887385570356
ACTN2,Alpha-actinin-2,Diet and food preferences,X20663.Liking for fruit,33160,0.0754779770682823,0.0392832507409148,-0.00151719438391069,0.152473148520475,0.0547166976458419
ACTN2,Alpha-actinin-2,Diet and food preferences,X20664.Liking for garlic,33160,0.00513079798428253,0.0338434072803434,-0.0612022802851905,0.0714638762537556,0.879502745710172
ACTN2,Alpha-actinin-2,Diet and food preferences,X20665.Liking for gherkins,33160,-0.00636182113662174,0.0332061013983423,-0.0714457798773726,0.0587221376041291,0.848071052153333
ACTN2,Alpha-actinin-2,Diet and food preferences,X20666.Liking for globe artichoke,33160,-0.0280217093137984,0.0337316806852525,-0.0941358034568933,0.0380923848292964,0.406152487865877
ACTN2,Alpha-actinin-2,Diet and food preferences,X20667.Liking for goat's cheese,33160,0.0218215028057415,0.0331639690663021,-0.0431798765642106,0.0868228821756937,0.510563076742057
ACTN2,Alpha-actinin-2,Diet and food preferences,X20668.Liking for going to a cafe,33160,-0.0237652339466792,0.033656027834087,-0.0897310485014896,0.0422005806081312,0.480131694207604
ACTN2,Alpha-actinin-2,Diet and food preferences,X20669.Liking for going to the gym,33160,0.0504579244215712,0.0332639570228438,-0.0147394313432027,0.115655280186345,0.129329576223638
ACTN2,Alpha-actinin-2,Diet and food preferences,X20670.Liking for going to the pub,33160,-0.039894335332663,0.0333437430570363,-0.105248071724454,0.0254594010591282,0.231551104582056
ACTN2,Alpha-actinin-2,Diet and food preferences,X20671.Liking for grapefruit,33160,0.0167293797602695,0.0335536409483002,-0.049035756498399,0.082494516018938,0.618083589224835
ACTN2,Alpha-actinin-2,Diet and food preferences,X20672.Liking for green olives,33160,0.00311609964782682,0.0337577181395067,-0.0630490279056063,0.0692812272012599,0.926455641539711
ACTN2,Alpha-actinin-2,Diet and food preferences,X20673.Liking for haddock,33160,0.000570461221938529,0.0341308927380591,-0.0663260885446572,0.0674670109885343,0.986665220526494
ACTN2,Alpha-actinin-2,Diet and food preferences,X20674.Liking for ham,33160,-0.0356820905861593,0.033047450548063,-0.100455093660363,0.0290909124880442,0.280295508682503
ACTN2,Alpha-actinin-2,Diet and food preferences,X20675.Liking for hard cheese,33160,0.0136701165803652,0.0346899139685782,-0.054322114798048,0.0816623479587785,0.693541951453297
ACTN2,Alpha-actinin-2,Diet and food preferences,X20676.Liking for herring,33160,0.0631127435138258,0.0333334648579963,-0.00222084760784698,0.128446334635499,0.0583411940979948
ACTN2,Alpha-actinin-2,Diet and food preferences,X20677.Liking for honey,33160,0.0234827476413152,0.0329541781066671,-0.0411074414477522,0.0880729367303827,0.476119931268717
ACTN2,Alpha-actinin-2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33160,-0.0391748271393469,0.0333196833048402,-0.104481406416834,0.0261317521381399,0.23973645174522
ACTN2,Alpha-actinin-2,Diet and food preferences,X20679.Liking for ice cream,33160,0.0338458222298562,0.033691802004476,-0.0321901096989168,0.0998817541586291,0.315131194764157
ACTN2,Alpha-actinin-2,Diet and food preferences,X20680.Liking for jam,33160,-0.016294311547803,0.0334709758753687,-0.0818974242635256,0.0493088011679197,0.62639877354657
ACTN2,Alpha-actinin-2,Diet and food preferences,X20681.Liking for kiwi fruit,33160,0.0466338154302497,0.033531885741082,-0.0190886806222711,0.11235631148277,0.164342746090196
ACTN2,Alpha-actinin-2,Diet and food preferences,X20682.Liking for lager,33160,-0.0362150898594824,0.0335144467070629,-0.101903405405326,0.0294732256863609,0.279913288448555
ACTN2,Alpha-actinin-2,Diet and food preferences,X20683.Liking for lamb,33160,0.0226083212970414,0.0333959864288817,-0.0428478121035668,0.0880644546976496,0.498438423472499
ACTN2,Alpha-actinin-2,Diet and food preferences,X20684.Liking for lemons,33160,-0.0036646117274824,0.033423120444515,-0.0691739277987318,0.061844704343767,0.912695023603251
ACTN2,Alpha-actinin-2,Diet and food preferences,X20685.Liking for lentils or beans,33160,0.00493027365762978,0.0339506229775842,-0.0616129473784352,0.0714734946936948,0.884541372815153
ACTN2,Alpha-actinin-2,Diet and food preferences,X20686.Liking for liver,33160,-0.0112527831004774,0.0331056543401932,-0.0761398656072561,0.0536342994063012,0.733936148822411
ACTN2,Alpha-actinin-2,Diet and food preferences,X20687.Liking for mackerel,33160,-0.0114238646205266,0.0337142727516318,-0.077503839213725,0.0546561099726718,0.734735753395836
ACTN2,Alpha-actinin-2,Diet and food preferences,X20688.Liking for marzipan,33160,0.100744748423048,0.0330540979757545,0.0359587163905695,0.165530780455527,0.00231157781450168
ACTN2,Alpha-actinin-2,Diet and food preferences,X20689.Liking for mayonnaise,33160,0.0119584763039256,0.0332326884349787,-0.0531775930286328,0.0770945456364839,0.718974945402027
ACTN2,Alpha-actinin-2,Diet and food preferences,X20690.Liking for melon,33160,0.0161107855555761,0.0352998143385736,-0.0530768505480283,0.0852984216591804,0.648114772560352
ACTN2,Alpha-actinin-2,Diet and food preferences,X20691.Liking for milk chocolate,33160,0.0152947796293452,0.0332648247719062,-0.0499042769235909,0.0804938361822813,0.645679620958203
ACTN2,Alpha-actinin-2,Diet and food preferences,X20692.Liking for mushrooms,33160,-0.0199640200680453,0.0346247305037134,-0.0878284918553236,0.0479004517192329,0.564236317503307
ACTN2,Alpha-actinin-2,Diet and food preferences,X20694.Liking for orange juice,33160,-0.0130826655902387,0.0330172636170879,-0.077796502279731,0.0516311710992535,0.691939825050881
ACTN2,Alpha-actinin-2,Diet and food preferences,X20695.Liking for oranges,33160,0.0314132517928426,0.0345181970502372,-0.0362424144256223,0.0990689180113075,0.362821866596363
ACTN2,Alpha-actinin-2,Diet and food preferences,X20696.Liking for pasta,33160,-0.071120498230748,0.0338982554903122,-0.13756107899176,-0.0046799174697361,0.0359288138922873
ACTN2,Alpha-actinin-2,Diet and food preferences,X20697.Liking for pears,33160,0.030830899765844,0.0344782713918062,-0.0367465121620962,0.0984083116937842,0.371232967776082
ACTN2,Alpha-actinin-2,Diet and food preferences,X20698.Liking for pizza,33160,-0.0839756306561852,0.0329343890763919,-0.148527033245913,-0.0194242280664572,0.0107959180425018
ACTN2,Alpha-actinin-2,Diet and food preferences,X20699.Liking for plain yogurt,33160,0.0790646531131462,0.0338597686356974,0.0126995065871794,0.145429799639113,0.0195628126801658
ACTN2,Alpha-actinin-2,Diet and food preferences,X20700.Liking for plums,33160,0.0326056053597828,0.0346473228449259,-0.0353031474162721,0.100514358135838,0.346694391309633
ACTN2,Alpha-actinin-2,Diet and food preferences,X20701.Liking for pollock,33160,-0.012714704184519,0.0335130726623467,-0.0784003266027185,0.0529709182336804,0.704403558172229
ACTN2,Alpha-actinin-2,Diet and food preferences,X20702.Liking for pork chop,33160,-0.0684853598460549,0.0329275271463652,-0.133023313052931,-0.0039474066391791,0.0375655976324308
ACTN2,Alpha-actinin-2,Diet and food preferences,X20703.Liking for porridge,33160,0.0414984730688407,0.0344112240002994,-0.0259475259717461,0.108944472109428,0.227866683492952
ACTN2,Alpha-actinin-2,Diet and food preferences,X20704.Liking for potato crisps,33160,-0.0643882170589559,0.0333438796227302,-0.129742221119507,0.000965787001595345,0.053511108920921
ACTN2,Alpha-actinin-2,Diet and food preferences,X20705.Liking for potatoes,33160,0.0132469509682427,0.0337490265921274,-0.052901141152327,0.0793950430888124,0.694688401312974
ACTN2,Alpha-actinin-2,Diet and food preferences,X20706.Liking for prawns,33160,-0.0839903547610663,0.0341250914531871,-0.150875534009313,-0.0171051755128197,0.0138646869908417
ACTN2,Alpha-actinin-2,Diet and food preferences,X20707.Liking for raw carrots,33160,0.0386712861250223,0.0342735501411602,-0.0285048721516517,0.105847444401696,0.259218946617225
ACTN2,Alpha-actinin-2,Diet and food preferences,X20708.Liking for red meat,33160,-0.0174363606123664,0.0329677626397746,-0.0820531753863246,0.0471804541615918,0.596894398535736
ACTN2,Alpha-actinin-2,Diet and food preferences,X20709.Liking for red wine,33160,-0.0395357504612193,0.0331487974982133,-0.104507393557717,0.0254358926352788,0.233029111542674
ACTN2,Alpha-actinin-2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33160,-0.04801919030714,0.0351831525594071,-0.116978169323578,0.020939788709298,0.172340284035389
ACTN2,Alpha-actinin-2,Diet and food preferences,X20711.Liking for roast chicken,33160,0.00065270404525052,0.0354888704745121,-0.0689054820847933,0.0702108901752943,0.985326719443657
ACTN2,Alpha-actinin-2,Diet and food preferences,X20712.Liking for salad dressing,33160,0.0206121672451561,0.0332931612389123,-0.044642428783112,0.0858667632734242,0.535859353038277
ACTN2,Alpha-actinin-2,Diet and food preferences,X20713.Liking for salad leaves,33160,0.0932815069639655,0.0353598590247565,0.0239761832754427,0.162586830652488,0.00835297237223947
ACTN2,Alpha-actinin-2,Diet and food preferences,X20714.Liking for salami,33160,-0.052483095125688,0.0332715683028331,-0.117695368999241,0.0127291787478648,0.114736260340072
ACTN2,Alpha-actinin-2,Diet and food preferences,X20715.Liking for salmon,33160,0.0542435168633815,0.03589958784378,-0.0161196753104272,0.12460670903719,0.13083017004526
ACTN2,Alpha-actinin-2,Diet and food preferences,X20716.Liking for salty foods,33160,-0.00168102608762896,0.0327903828981622,-0.0659501765680268,0.0625881243927689,0.959114875678838
ACTN2,Alpha-actinin-2,Diet and food preferences,X20717.Liking for salty pretzels,33160,-0.0603303164534124,0.0335293110476087,-0.126047766106725,0.00538713319990075,0.0720010379326856
ACTN2,Alpha-actinin-2,Diet and food preferences,X20718.Liking for sardines,33160,0.042230582013075,0.0338702742162402,-0.0241551554507559,0.108616319476906,0.212492238391316
ACTN2,Alpha-actinin-2,Diet and food preferences,X20719.Liking for sausages (meat),33160,-0.0344781658332483,0.0329372722854885,-0.0990352195128058,0.0300788878463092,0.295228908895591
ACTN2,Alpha-actinin-2,Diet and food preferences,X20720.Liking for savoury biscuits,33160,-0.0696562307338257,0.0329246514629252,-0.134188547601159,-0.00512391386649223,0.0344050163828583
ACTN2,Alpha-actinin-2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33160,-0.0776918907260781,0.03370054051401,-0.143744950133538,-0.0116388313186184,0.0211698143687433
ACTN2,Alpha-actinin-2,Diet and food preferences,X20722.Liking for skimmed milk,33160,-0.0282642461368015,0.0335335618673382,-0.0939900273967843,0.0374615351231813,0.399327448762836
ACTN2,Alpha-actinin-2,Diet and food preferences,X20723.Liking for smoked fish,33160,-0.021892903498906,0.0335194094567677,-0.0875909460341707,0.0438051390363587,0.513682588189818
ACTN2,Alpha-actinin-2,Diet and food preferences,X20724.Liking for soft cheese,33160,-0.0417010139165608,0.0337323752820168,-0.107816469469314,0.024414441636192,0.216406023920544
ACTN2,Alpha-actinin-2,Diet and food preferences,X20725.Liking for soy sauce,33160,-0.0584143797527771,0.0333905832497316,-0.123859922922251,0.0070311634166968,0.080252541313229
ACTN2,Alpha-actinin-2,Diet and food preferences,X20726.Liking for soya milk,33160,-0.00913881222544095,0.0333386126299508,-0.0744824929801444,0.0562048685292625,0.783998181825549
ACTN2,Alpha-actinin-2,Diet and food preferences,X20727.Liking for spicy foods,33160,-0.0713388228122887,0.0333047017357295,-0.136616038214319,-0.00606160741025898,0.0322207998262572
ACTN2,Alpha-actinin-2,Diet and food preferences,X20728.Liking for spinach,33160,0.0348911213010577,0.0339421266151899,-0.0316354468647146,0.10141768946683,0.303997602001453
ACTN2,Alpha-actinin-2,Diet and food preferences,X20729.Liking for spirits,33160,-0.0586830463335412,0.0331704276706941,-0.123697084568102,0.00633099190101918,0.0769059694546803
ACTN2,Alpha-actinin-2,Diet and food preferences,X20730.Liking for strawberries,33160,0.0277363149075825,0.0381372019807955,-0.0470126009747767,0.102485230789942,0.467075775395187
ACTN2,Alpha-actinin-2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33160,0.012743565832496,0.0343643189708373,-0.0546104993503452,0.0800976310153372,0.710767865325095
ACTN2,Alpha-actinin-2,Diet and food preferences,X20732.Liking for sweet foods,33160,0.0164201942715125,0.033160269477192,-0.0485739339037837,0.0814143224468087,0.620487872243897
ACTN2,Alpha-actinin-2,Diet and food preferences,X20733.Liking for taking the stairs,33160,0.0195654344111503,0.0344725424435287,-0.048000748778166,0.0871316176004666,0.570344515851709
ACTN2,Alpha-actinin-2,Diet and food preferences,X20734.Liking for tea with sugar,33160,0.00497048581333772,0.0444476554352822,-0.0821469188398154,0.0920878904664909,0.910962483791089
ACTN2,Alpha-actinin-2,Diet and food preferences,X20735.Liking for tea without sugar,33160,0.0370419217414609,0.0358350926368739,-0.0331948598268119,0.107278703309734,0.301315784786484
ACTN2,Alpha-actinin-2,Diet and food preferences,X20736.Liking for tomato ketchup,33160,-0.0348062533029423,0.0331466998596698,-0.0997737850278952,0.0301612784220106,0.293716513163459
ACTN2,Alpha-actinin-2,Diet and food preferences,X20737.Liking for tinned tuna,33160,-0.012626766547866,0.0331667388288061,-0.077633574652326,0.0523800415565939,0.703430934401578
ACTN2,Alpha-actinin-2,Diet and food preferences,X20738.Liking for turnip (white),33160,-0.040988409552157,0.0331398365120342,-0.105942489115744,0.0239656700114299,0.216182856501197
ACTN2,Alpha-actinin-2,Diet and food preferences,X20739.Liking for vegetables,33160,0.0864656951242475,0.0395488599702832,0.00894992958249241,0.163981460666003,0.0288201775275022
ACTN2,Alpha-actinin-2,Diet and food preferences,X20740.Liking for vinegar,33160,-0.0181540495717766,0.0333939404701457,-0.0836061728932621,0.0472980737497089,0.586707945801522
ACTN2,Alpha-actinin-2,Diet and food preferences,X20741.Liking for watching television,33160,-0.0447368989643156,0.0331544994034511,-0.10971971779508,0.0202459198664485,0.177260898135405
ACTN2,Alpha-actinin-2,Diet and food preferences,X20742.Liking for whisky,33160,-0.0325219335714584,0.0352536862614043,-0.101619158643811,0.0365752915008939,0.356287381471172
ACTN2,Alpha-actinin-2,Diet and food preferences,X20743.Liking for white bread,33160,-0.0988730437470669,0.0335306694685816,-0.164593155905487,-0.0331529315886469,0.00319926680923552
ACTN2,Alpha-actinin-2,Diet and food preferences,X20744.Liking for white rice,33160,-0.0642243114917832,0.0335915202771272,-0.130063691234952,0.00161506825138603,0.0559192260646025
ACTN2,Alpha-actinin-2,Diet and food preferences,X20745.Liking for white wine,33160,0.0100183450181023,0.0333730234596844,-0.0553927809628792,0.0754294709990838,0.764037186187117
ACTN2,Alpha-actinin-2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33160,0.0536105042491435,0.0343436648463921,-0.013703078849785,0.120924087348072,0.118559829180736
ACTN2,Alpha-actinin-2,Diet and food preferences,X20747.Liking for whole milk,33160,0.0224099851434015,0.0330526547568927,-0.0423732181801081,0.0871931884669111,0.497784255305793
ACTN2,Alpha-actinin-2,Diet and food preferences,X20748.Liking for wholemeal bread,33160,0.0677724963019491,0.0357968813459153,-0.00238939113604489,0.137934383739943,0.0583575994367157
ACTN2,Alpha-actinin-2,Diet and food preferences,X20749.Liking for working up a sweat,33160,0.0402531467001916,0.0338355741883039,-0.026064578708884,0.106570872109267,0.234208832030966
ACTN2,Alpha-actinin-2,Physical measures,X21001.Body mass index (BMI),47803,-0.0325220850721116,0.0143881844849824,-0.0607229266626771,-0.00432124348154611,0.0238097738042175
ACTN2,Alpha-actinin-2,Physical measures,X21002.Weight,47810,0.060460099899251,0.00894850872060789,0.0429210228068595,0.0779991769916425,1.44744739533659e-11
ACTN2,Alpha-actinin-2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32251,0.00265445244445113,0.0066310967480251,-0.0103424971816781,0.0156514020705803,0.68894382044609
ACTN2,Alpha-actinin-2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32688,-0.0257262630615725,0.0353206449722847,-0.0949547272072505,0.0435022010841055,0.466411916905788
ACTN2,Alpha-actinin-2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32701,-0.0342032940161682,0.0370312450373179,-0.106784534289311,0.0383779462569749,0.35570425401998
ACTN2,Alpha-actinin-2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32702,0.0826983612986903,0.0368142168681696,0.0105424962370778,0.154854226360303,0.0247066567509199
ACTN2,Alpha-actinin-2,Health and medical history,X21040.Satisfaction with bowel habits,32654,0.000817314033103592,0.0346643969301051,-0.0671249039499024,0.0687595320161096,0.981189866662312
ACTN2,Alpha-actinin-2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32639,0.0220308285405416,0.0356055468274208,-0.0477560432412031,0.0918177003222863,0.536100215593782
ACTN2,Alpha-actinin-2,Health and medical history,X21042.Greatest number of times bowels opened per day,32653,-0.0377759950665731,0.037050024219775,-0.110394042537332,0.0348420524041858,0.307950969566467
ACTN2,Alpha-actinin-2,Health and medical history,X21043.Least number of times bowels opened per week,32572,0.0678624903234984,0.0367169257683683,-0.00410268418250348,0.1398276648295,0.0646008238124711
ACTN2,Alpha-actinin-2,Health and medical history,X21044.Average number of times bowels opened per day,32621,0.0408671126175515,0.0415932090514379,-0.0406555771232667,0.12238980235837,0.325861581336771
ACTN2,Alpha-actinin-2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32704,0.0519603792779998,0.0369999684537209,-0.0205595588912931,0.124480317447293,0.160256527191151
ACTN2,Alpha-actinin-2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32700,0.0354990045201918,0.0375484709753196,-0.0380959985914346,0.109094007631818,0.344473156969932
ACTN2,Alpha-actinin-2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32702,-0.0811592720204649,0.0430449626712323,-0.16552739885608,0.00320885481515044,0.059403763157952
ACTN2,Alpha-actinin-2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32701,0.0522102730569754,0.0391529671005044,-0.0245295424600133,0.128950088573964,0.182406347359967
ACTN2,Alpha-actinin-2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32698,0.00275326876099815,0.0577534943964155,-0.110443580255976,0.115950117777973,0.961978194507366
ACTN2,Alpha-actinin-2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32699,0.0424177358385281,0.042908844447565,-0.0416835992786993,0.126519070955755,0.322910110321161
ACTN2,Alpha-actinin-2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32699,0.0217604444838313,0.109045623089192,-0.191968976770985,0.235489865738648,0.841834655570878
ACTN2,Alpha-actinin-2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32704,0.0365356295891883,0.0406524540626336,-0.0431431803735736,0.11621443955195,0.368822069826147
ACTN2,Alpha-actinin-2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32702,-0.00462645246790522,0.0425447116913605,-0.0880140873829719,0.0787611824471614,0.913408739702475
ACTN2,Alpha-actinin-2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32471,0.0147892890235469,0.0378924373311538,-0.0594798881455146,0.0890584661926085,0.696327615009714
ACTN2,Alpha-actinin-2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32700,0.0119482329044786,0.0385688627587501,-0.0636467381026716,0.0875432039116288,0.756728781292999
ACTN2,Alpha-actinin-2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32701,0.0215625233240151,0.0502741069552588,-0.0769747263082922,0.120099772956322,0.668007797205906
ACTN2,Alpha-actinin-2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32704,-0.0117694380299474,0.0367704672256471,-0.0838395537922156,0.0603006777323209,0.748916886200273
ACTN2,Alpha-actinin-2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32703,-0.0224059330040128,0.0367990511142588,-0.09453207318796,0.0497202071799343,0.542625668351554
ACTN2,Alpha-actinin-2,Working and living environment,X21100.Water hardness (USGS classification),47686,0.0557467094791808,0.0222831751739223,0.012071686138293,0.0994217328200686,0.0123652880335534
ACTN2,Alpha-actinin-2,Lifestyle factors,X2139.Age first had sexual intercourse,44566,-0.00443523313979327,0.00457805210586109,-0.013408215267281,0.00453774898769447,0.332654863131739
ACTN2,Alpha-actinin-2,Health and medical history,X2149.Lifetime number of sexual partners,43284,0.0244003381718135,0.0247785360395944,-0.0241655924657916,0.0729662688094186,0.32476598605893
ACTN2,Alpha-actinin-2,Physical activities,X22032.IPAQ activity group,42506,0.207374385260435,0.025249938844017,0.157884505126162,0.256864265394708,2.30404167346246e-16
ACTN2,Alpha-actinin-2,Physical activities,X22033.Summed days activity,43089,0.0382438825571531,0.0043751529313185,0.0296685828117688,0.0468191823025374,2.49994024121008e-18
ACTN2,Alpha-actinin-2,Physical activities,X22034.Summed minutes activity,42506,0.0333113078408318,0.0043739666074205,0.0247383332902877,0.041884282391376,2.74944001939561e-14
ACTN2,Alpha-actinin-2,Physical activities,X22037.MET minutes per week for walking,41621,0.0243606892712043,0.00444891247541726,0.0156408208193865,0.0330805577230221,4.42024785799268e-08
ACTN2,Alpha-actinin-2,Physical activities,X22038.MET minutes per week for moderate activity,42506,0.0383031240146166,0.00432270581447133,0.0298306206182528,0.0467756274109804,8.65986797910851e-19
ACTN2,Alpha-actinin-2,Physical activities,X22039.MET minutes per week for vigorous activity,42506,0.125146576278757,0.0248563630491032,0.0764281047025146,0.173865047854999,4.82977582292119e-07
ACTN2,Alpha-actinin-2,Physical activities,X22040.Summed MET minutes per week for all activity,41621,0.0393353085848277,0.0045229300081575,0.0304703657688391,0.0482002514008164,3.71539097294256e-18
ACTN2,Alpha-actinin-2,Eye measures,X2217.Age started wearing glasses or contact lenses,44605,0.00118297440634878,0.00411618609142235,-0.00688475033283902,0.00925069914553659,0.773812266707421
ACTN2,Alpha-actinin-2,Working and living environment,X22501.Year ended full time education,30110,0.0185874478979395,0.0201980116136212,-0.0210006548647581,0.058175550660637,0.357475474028184
ACTN2,Alpha-actinin-2,Lifestyle factors,X22506.Tobacco smoking,30080,0.111715737102627,0.0945419045774195,-0.0735863958691156,0.297017870074369,0.237393308931598
ACTN2,Alpha-actinin-2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46316,0.0441649909997892,0.0517164153243112,-0.0571991830358608,0.145529165035439,0.393123213747337
ACTN2,Alpha-actinin-2,Physical measures,X23098.Weight,47454,0.0622210486520283,0.00902503388698149,0.0445319822335446,0.079910115070512,5.554166962894e-12
ACTN2,Alpha-actinin-2,Physical measures,X23099.Body fat percentage,47455,-0.113691327514025,0.0092365272428749,-0.13179492091006,-0.0955877341179906,1.04357449150737e-34
ACTN2,Alpha-actinin-2,Physical measures,X23100.Whole body fat mass,47448,-0.0399261602316215,0.00888301670670844,-0.0573368729767701,-0.022515447486473,7.00203054284523e-06
ACTN2,Alpha-actinin-2,Physical measures,X23101.Whole body fat-free mass,47454,0.104971340710132,0.00737881270501235,0.0905088678083078,0.119433813611956,9.87377619617022e-46
ACTN2,Alpha-actinin-2,Physical measures,X23102.Whole body water mass,47454,0.107091887116643,0.0074055738165481,0.0925769624362085,0.121606811797077,3.44334932336012e-47
ACTN2,Alpha-actinin-2,Physical measures,X23104.Body mass index (BMI),47454,-0.0308322218850525,0.0145842988473444,-0.0594174476258476,-0.00224699614425749,0.0345200608588695
ACTN2,Alpha-actinin-2,Physical measures,X23105.Basal metabolic rate,47452,0.105976224673566,0.00805143270394751,0.0901954165738289,0.121757032773303,2.00545859192563e-39
ACTN2,Alpha-actinin-2,Physical measures,X23106.Impedance of whole body,47448,-0.0930781418812274,0.00603746081962748,-0.104911565087697,-0.0812447186747576,2.33560418546319e-53
ACTN2,Alpha-actinin-2,Physical measures,X23107.Impedance of leg (right),47451,-0.0856198580109881,0.00494856514562707,-0.0953190456964171,-0.075920670325559,1.20207464346969e-66
ACTN2,Alpha-actinin-2,Physical measures,X23108.Impedance of leg (left),47450,-0.0807176734190657,0.00489885904365141,-0.0903194371446225,-0.0711159096935089,1.19906275956954e-60
ACTN2,Alpha-actinin-2,Physical measures,X23109.Impedance of arm (right),47443,-0.0583474408257539,0.00605892948450601,-0.0702229426153857,-0.0464719390361221,6.57049436745347e-22
ACTN2,Alpha-actinin-2,Physical measures,X23110.Impedance of arm (left),47449,-0.0633071229717927,0.0060749851173973,-0.0752140938018914,-0.051400152141694,2.26607056487542e-25
ACTN2,Alpha-actinin-2,Physical measures,X23111.Leg fat percentage (right),47450,-0.235402760462556,0.0145176063315913,-0.263857268872475,-0.206948252052637,8.37823902246847e-59
ACTN2,Alpha-actinin-2,Physical measures,X23112.Leg fat mass (right),47449,-0.0713064214112113,0.016751338671399,-0.104139045207153,-0.0384737976152693,2.08232867877964e-05
ACTN2,Alpha-actinin-2,Physical measures,X23113.Leg fat-free mass (right),47449,0.114619332905202,0.00751070087474363,0.0998983591907041,0.129340306619699,2.51868036179309e-52
ACTN2,Alpha-actinin-2,Physical measures,X23114.Leg predicted mass (right),47448,0.114158355667004,0.00754120695692796,0.0993775900314249,0.128939121302583,1.61277271467119e-51
ACTN2,Alpha-actinin-2,Physical measures,X23115.Leg fat percentage (left),47445,-0.231170861955988,0.0150095948989478,-0.260589667957926,-0.201752055954051,2.94942483636504e-53
ACTN2,Alpha-actinin-2,Physical measures,X23116.Leg fat mass (left),47445,-0.0703980136790976,0.0168345666553222,-0.103393764323529,-0.037402263034666,2.90340165389942e-05
ACTN2,Alpha-actinin-2,Physical measures,X23117.Leg fat-free mass (left),47443,0.111958056114051,0.00770303227141666,0.0968601128620742,0.127055999366027,1.19562446099353e-47
ACTN2,Alpha-actinin-2,Physical measures,X23118.Leg predicted mass (left),47442,0.111408370783494,0.00773449071563729,0.096248768980845,0.126567972586143,7.80050283658812e-47
ACTN2,Alpha-actinin-2,Physical measures,X23119.Arm fat percentage (right),47442,-0.0954289153737914,0.0102468724186569,-0.115512785314359,-0.075345045433224,1.35115335854672e-20
ACTN2,Alpha-actinin-2,Physical measures,X23120.Arm fat mass (right),47439,-0.0300296507985789,0.00926999151724656,-0.0481988341723821,-0.0118604674247756,0.00119931641169247
ACTN2,Alpha-actinin-2,Physical measures,X23121.Arm fat-free mass (right),47441,0.080849440519479,0.00719719219120271,0.0667429438247217,0.0949559372142363,3.32793277326041e-29
ACTN2,Alpha-actinin-2,Physical measures,X23122.Arm predicted mass (right),47440,0.0803408159657505,0.00719136179266211,0.0662457468521328,0.0944358850793683,6.64789711472116e-29
ACTN2,Alpha-actinin-2,Physical measures,X23123.Arm fat percentage (left),47438,-0.114143595263742,0.0115011319729079,-0.136685813930642,-0.0916013765968429,3.62449002715087e-23
ACTN2,Alpha-actinin-2,Physical measures,X23124.Arm fat mass (left),47438,-0.0271514509315602,0.00950543526828436,-0.0457821040573975,-0.00852079780572283,0.00428841230110986
ACTN2,Alpha-actinin-2,Physical measures,X23125.Arm fat-free mass (left),47438,0.0834383295432802,0.00775789370255839,0.0682328578862658,0.0986438012002947,6.4860402402319e-27
ACTN2,Alpha-actinin-2,Physical measures,X23126.Arm predicted mass (left),47436,0.0815632684269557,0.00777186954234782,0.0663304041239539,0.0967961327299574,1.04483269634439e-25
ACTN2,Alpha-actinin-2,Physical measures,X23127.Trunk fat percentage,47435,-0.0554426252696251,0.00583976375482597,-0.066888562229084,-0.0439966883101662,2.43332224770262e-21
ACTN2,Alpha-actinin-2,Physical measures,X23128.Trunk fat mass,47431,-0.0297416950168607,0.00674561164537464,-0.042963093841795,-0.0165202961919264,1.04298986897651e-05
ACTN2,Alpha-actinin-2,Physical measures,X23129.Trunk fat-free mass,47426,0.0898503107080555,0.00688657949007223,0.0763526149075139,0.103348006508597,9.06051120714891e-39
ACTN2,Alpha-actinin-2,Physical measures,X23130.Trunk predicted mass,47423,0.088837066031288,0.00690040759781601,0.0753122671395686,0.102361864923007,8.50107983626955e-38
ACTN2,Alpha-actinin-2,NMR metabolomics,X23400.Total Cholesterol,37562,-0.0132288052595384,0.00519825613925496,-0.0234173872924782,-0.0030402232265987,0.0109436904675659
ACTN2,Alpha-actinin-2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37562,-0.0190273969118514,0.00502522612522913,-0.0288768401173005,-0.00917795370640228,0.000153542071084559
ACTN2,Alpha-actinin-2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37562,-0.0163936972460852,0.00502058112354811,-0.0262340362482395,-0.00655335824393092,0.00109629254178362
ACTN2,Alpha-actinin-2,NMR metabolomics,X23403.VLDL Cholesterol,37562,-0.0179729857246032,0.0049230450970776,-0.0276221541148753,-0.0083238173343311,0.000262455447613311
ACTN2,Alpha-actinin-2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37562,-0.0205061556716752,0.00502630387261035,-0.0303577112619915,-0.010654600081359,4.5347363387914e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23405.LDL Cholesterol,37562,-0.0208175575242052,0.0050249550818909,-0.0306664694847114,-0.010968645563699,3.45191407604829e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23406.HDL Cholesterol,37562,0.015069868569317,0.00579838227422259,0.00370503931184077,0.0264346978267933,0.00936064461192469
ACTN2,Alpha-actinin-2,NMR metabolomics,X23407.Total Triglycerides,37562,-0.0166443189188111,0.00531978733423497,-0.0270711020939117,-0.00621753574371058,0.00175932538921462
ACTN2,Alpha-actinin-2,NMR metabolomics,X23408.Triglycerides in VLDL,37562,-0.0187240961710532,0.00532518839964339,-0.0291614654343542,-0.0082867269077521,0.000439353061576329
ACTN2,Alpha-actinin-2,NMR metabolomics,X23409.Triglycerides in LDL,37562,-0.00493137691939923,0.0053069825937827,-0.0153330628032133,0.00547030896441487,0.352789991151866
ACTN2,Alpha-actinin-2,NMR metabolomics,X23410.Triglycerides in HDL,37562,-0.00844210027903574,0.00500148060161524,-0.0182450022582016,0.00136080170013012,0.0914503286803251
ACTN2,Alpha-actinin-2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37562,-0.00735731555121812,0.00529431778935141,-0.0177341784183469,0.00301954731591065,0.16465494735322
ACTN2,Alpha-actinin-2,NMR metabolomics,X23412.Phospholipids in VLDL,37562,-0.0181912342921843,0.00507120971295515,-0.0281308053295763,-0.00825166325479217,0.000335518005089029
ACTN2,Alpha-actinin-2,NMR metabolomics,X23413.Phospholipids in LDL,37562,-0.0210352320345256,0.00498795675264577,-0.0308116272697113,-0.0112588367993399,2.49010565427965e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23414.Phospholipids in HDL,37562,0.0125205204702177,0.00560871928735041,0.00152743066701092,0.0235136102734245,0.0256098877024305
ACTN2,Alpha-actinin-2,NMR metabolomics,X23415.Total Esterified Cholesterol,37562,-0.0128651412902472,0.00521550948821914,-0.0230875398871567,-0.0026427426933377,0.0136488254873369
ACTN2,Alpha-actinin-2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37562,-0.0170942228836438,0.00489162079696404,-0.0266817996456933,-0.00750664612159429,0.000476353194659472
ACTN2,Alpha-actinin-2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37562,-0.0213898635213683,0.00501428972541379,-0.0312178713831793,-0.0115618556595573,2.00600916258554e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37562,0.0142231398834413,0.00575946708342266,0.00293458439993289,0.0255116953669497,0.0135419524972906
ACTN2,Alpha-actinin-2,NMR metabolomics,X23419.Total Free Cholesterol,37562,-0.0137413162091312,0.00515323296967729,-0.0238416528296987,-0.00364097958856375,0.0076729903514406
ACTN2,Alpha-actinin-2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37562,-0.0188943824379009,0.0050118031815552,-0.028717516673749,-0.00907124820205266,0.000163979127943828
ACTN2,Alpha-actinin-2,NMR metabolomics,X23421.Free Cholesterol in LDL,37562,-0.0186704535496645,0.00506753580394517,-0.028602823725397,-0.00873808337393192,0.000230231648736723
ACTN2,Alpha-actinin-2,NMR metabolomics,X23422.Free Cholesterol in HDL,37562,0.0172246765441013,0.00582315625456287,0.00581129028515812,0.0286380628030446,0.00310232753007074
ACTN2,Alpha-actinin-2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37562,-0.014171233394532,0.00517708361175501,-0.0243183172735719,-0.0040241495154922,0.00620291963354648
ACTN2,Alpha-actinin-2,NMR metabolomics,X23424.Total Lipids in VLDL,37562,-0.0191335853604384,0.00517277610362059,-0.0292722265235348,-0.00899494419734208,0.000217419849998655
ACTN2,Alpha-actinin-2,NMR metabolomics,X23425.Total Lipids in LDL,37562,-0.0204672033960831,0.00501525575925382,-0.0302971046842206,-0.0106373021079456,4.51101593603815e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23426.Total Lipids in HDL,37562,0.0131406150603785,0.00568125167937984,0.00200536176879398,0.024275868351963,0.0207392023716228
ACTN2,Alpha-actinin-2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37562,-0.00865294866036415,0.0053144876027805,-0.0190693443618139,0.00176344704108563,0.103510504454338
ACTN2,Alpha-actinin-2,NMR metabolomics,X23428.Concentration of VLDL Particles,37562,-0.0168193548835839,0.00499571645289765,-0.0266109591312633,-0.0070277506359045,0.000762767363877297
ACTN2,Alpha-actinin-2,NMR metabolomics,X23429.Concentration of LDL Particles,37562,-0.017849872292178,0.0049752504568585,-0.0276013631876207,-0.00809838139673533,0.000334780327103248
ACTN2,Alpha-actinin-2,NMR metabolomics,X23430.Concentration of HDL Particles,37562,-0.0058788939445144,0.00532179887328708,-0.0163096197361571,0.00455183184712827,0.269317799726258
ACTN2,Alpha-actinin-2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37562,-0.0233926176685428,0.00561737971841013,-0.0344026819166267,-0.012382553420459,3.14267409523962e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37562,0.0164232659738735,0.00511614337025456,0.00639562496817459,0.0264509069795725,0.00133014432706511
ACTN2,Alpha-actinin-2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37562,0.0399739735367901,0.00607723600987542,0.0280625909574343,0.051885356116146,4.9605717195743e-11
ACTN2,Alpha-actinin-2,NMR metabolomics,X23434.Phosphoglycerides,37549,-0.00449002145254106,0.00531544801268972,-0.0149082995574129,0.00592825665233078,0.398287220996187
ACTN2,Alpha-actinin-2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37549,-0.0178294595484677,0.0056416845556367,-0.0288871612775157,-0.0067717578194198,0.00157961362233139
ACTN2,Alpha-actinin-2,NMR metabolomics,X23436.Total Cholines,37549,-0.00419035470335634,0.00533246058243931,-0.0146419774449374,0.00626126803822472,0.431987105874311
ACTN2,Alpha-actinin-2,NMR metabolomics,X23437.Phosphatidylcholines,37549,-0.00455400283533806,0.00533419724895024,-0.0150090294432805,0.00590102377260441,0.393266209525546
ACTN2,Alpha-actinin-2,NMR metabolomics,X23438.Sphingomyelins,37548,-0.00307274025206385,0.00536609024528374,-0.01359027713282,0.00744479662869228,0.566910626618205
ACTN2,Alpha-actinin-2,NMR metabolomics,X23439.Apolipoprotein B,37562,-0.0172352679100543,0.00497486947209864,-0.0269860120753677,-0.00748452374474099,0.000532983080702084
ACTN2,Alpha-actinin-2,NMR metabolomics,X23440.Apolipoprotein A1,37562,0.00514141903182112,0.00550138359410297,-0.0056412928126207,0.0159241308762629,0.350028005140545
ACTN2,Alpha-actinin-2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37562,-0.0172275647747265,0.00501109773152226,-0.0270493163285102,-0.00740581322094291,0.000588103492254092
ACTN2,Alpha-actinin-2,NMR metabolomics,X23442.Total Fatty Acids,37549,-0.0107956191122337,0.00533088524585626,-0.021244154194112,-0.000347084030355466,0.0428765052980339
ACTN2,Alpha-actinin-2,NMR metabolomics,X23443.Degree of Unsaturation,37549,-0.00220603617748931,0.00555473570551547,-0.0130933181602996,0.008681245805321,0.691266920769861
ACTN2,Alpha-actinin-2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37549,-0.00658190669714934,0.00519931844135344,-0.0167725708422021,0.0036087574479034,0.205565241275543
ACTN2,Alpha-actinin-2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37549,-0.013039507964219,0.00516170357425177,-0.0231564469697525,-0.00292256895868552,0.0115419886923414
ACTN2,Alpha-actinin-2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37549,-0.0124261260961099,0.00521010568608151,-0.0226379332408296,-0.0022143189513901,0.0170930450386083
ACTN2,Alpha-actinin-2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37549,-0.00793549578660804,0.00546523804939996,-0.018647362363432,0.00277637079021588,0.146527078488708
ACTN2,Alpha-actinin-2,NMR metabolomics,X23448.Saturated Fatty Acids,37549,-0.00990193920937961,0.00543379381462938,-0.0205521750860532,0.000748296667293966,0.0684340365600717
ACTN2,Alpha-actinin-2,NMR metabolomics,X23449.Linoleic Acid,37549,-0.012104427287642,0.00510946164962246,-0.022118972120902,-0.002089882454382,0.0178496114279792
ACTN2,Alpha-actinin-2,NMR metabolomics,X23450.Docosahexaenoic Acid,37549,-0.00157637881018435,0.00546379610917127,-0.01228541918416,0.00913266156379134,0.772958281989005
ACTN2,Alpha-actinin-2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37549,-0.00199609645509624,0.0051751331483949,-0.0121393574259503,0.00814716451575776,0.699718314722352
ACTN2,Alpha-actinin-2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37549,-2.71806977143422e-05,0.00582545728653177,-0.0114450769793166,0.0113907155838879,0.996277276558251
ACTN2,Alpha-actinin-2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37549,0.000119686597828567,0.00583510852787119,-0.011317126116799,0.0115564993124561,0.983635682336464
ACTN2,Alpha-actinin-2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37549,-0.000170666785492935,0.00575607744266634,-0.011452578573119,0.0111112450021331,0.976346766538734
ACTN2,Alpha-actinin-2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37549,-0.00165223714624681,0.00540782549291486,-0.0122515751123599,0.00894710081986632,0.759969602033323
ACTN2,Alpha-actinin-2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37549,-0.00405476526820984,0.00559402578292669,-0.0150190558027462,0.00690952526632648,0.468564061462208
ACTN2,Alpha-actinin-2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37549,0.0059835447225029,0.00551857201795483,-0.00483285643268858,0.0167999458776944,0.278271274987186
ACTN2,Alpha-actinin-2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37549,0.000389011594161898,0.0058149647356957,-0.0110083192878017,0.0117863424761255,0.946663641174669
ACTN2,Alpha-actinin-2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37547,0.0019472237083679,0.00515719351169718,-0.00816087557455858,0.0120553229912944,0.705752981788596
ACTN2,Alpha-actinin-2,NMR metabolomics,X23460.Alanine,37555,-0.0341122295193033,0.00498629783709564,-0.0438853732800107,-0.0243390857585958,8.20243503756544e-12
ACTN2,Alpha-actinin-2,NMR metabolomics,X23461.Glutamine,37519,0.0142087489266021,0.00504251578442326,0.00432541798913256,0.0240920798640717,0.00484280789311842
ACTN2,Alpha-actinin-2,NMR metabolomics,X23462.Glycine,37544,0.00174829912892394,0.0047881216109594,-0.00763641922855648,0.0111330174864044,0.715018350927367
ACTN2,Alpha-actinin-2,NMR metabolomics,X23463.Histidine,37545,0.00160580288745143,0.0048923627891023,-0.00798322817918908,0.0111948339540919,0.742745696485832
ACTN2,Alpha-actinin-2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37552,-0.000838198517041729,0.00501687653619604,-0.010671276527986,0.00899487949390251,0.8673130084773
ACTN2,Alpha-actinin-2,NMR metabolomics,X23465.Isoleucine,37558,0.0206063032574071,0.00491343074835595,0.0109759789906294,0.0302366275241847,2.76034918762948e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23466.Leucine,37559,0.00474647520889252,0.0050102183070553,-0.00507355267293587,0.0145665030907209,0.343473361055952
ACTN2,Alpha-actinin-2,NMR metabolomics,X23467.Valine,37552,-0.0125607955807371,0.0050620631082976,-0.0224824392730004,-0.00263915188847383,0.0131006982563452
ACTN2,Alpha-actinin-2,NMR metabolomics,X23468.Phenylalanine,37558,0.030151754111914,0.00488460448821634,0.02057792931501,0.0397255789088181,6.90644868280234e-10
ACTN2,Alpha-actinin-2,NMR metabolomics,X23469.Tyrosine,37545,0.00293373705011748,0.00493020391204935,-0.00672946261749925,0.0125969367177342,0.551817728280047
ACTN2,Alpha-actinin-2,NMR metabolomics,X23470.Glucose,37538,0.010739971587718,0.00521690293580783,0.000514841833534662,0.0209651013419013,0.0395439572656788
ACTN2,Alpha-actinin-2,NMR metabolomics,X23471.Lactate,37537,-0.0283221150330767,0.00490193828086601,-0.0379299140635741,-0.0187143160025794,7.74354530934138e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23472.Pyruvate,37521,-0.00982289540102479,0.00501956337826111,-0.0196612396224166,1.54488203669874e-05,0.0503778664622706
ACTN2,Alpha-actinin-2,NMR metabolomics,X23473.Citrate,37560,0.0417658683333691,0.00497539130041111,0.0320141013845633,0.0515176352821749,5.15603755073932e-17
ACTN2,Alpha-actinin-2,NMR metabolomics,X23474.3-Hydroxybutyrate,37401,0.0262819005575759,0.00470927184393692,0.0170517277434595,0.0355120733716922,2.44105086755807e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23475.Acetate,37552,0.0295118853890804,0.00504209591843019,0.0196293773889573,0.0393943933892036,4.94044276224474e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23476.Acetoacetate,37561,0.038356594801673,0.00485900847551048,0.0288329381896725,0.0478802514136736,3.16033280520327e-15
ACTN2,Alpha-actinin-2,NMR metabolomics,X23477.Acetone,37561,0.0476031843020503,0.0048663129190444,0.0380652109807232,0.0571411576233773,1.60341424028675e-22
ACTN2,Alpha-actinin-2,NMR metabolomics,X23478.Creatinine,37173,0.0757001411587045,0.0058417027289004,0.0642504038100597,0.0871498785073493,3.66332668599394e-38
ACTN2,Alpha-actinin-2,NMR metabolomics,X23479.Albumin,37560,0.00630491777911815,0.00504077954531588,-0.00357501012970098,0.0161848456879373,0.211036243371378
ACTN2,Alpha-actinin-2,NMR metabolomics,X23480.Glycoprotein Acetyls,37562,-0.0147195062379155,0.00538486986319294,-0.0252738511697737,-0.00416516130605738,0.00627504397260699
ACTN2,Alpha-actinin-2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37562,-0.0102260031673547,0.00538418822773914,-0.0207790120937234,0.000327005759014008,0.0575514999102646
ACTN2,Alpha-actinin-2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37562,-0.00929526742203441,0.00538723748713239,-0.0198542528968139,0.00126371805274507,0.0844747023306575
ACTN2,Alpha-actinin-2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37562,-0.012180818290023,0.00530436124136543,-0.0225773663230992,-0.00178427025694674,0.0216699750342393
ACTN2,Alpha-actinin-2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37562,-0.0147310086005352,0.00529113450679143,-0.0251016322338464,-0.00436038496722402,0.00537546197528076
ACTN2,Alpha-actinin-2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37562,-0.0156155950571082,0.00524955502240324,-0.0259047229010186,-0.0053264672131979,0.00293856264183353
ACTN2,Alpha-actinin-2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37562,-0.0116329269437102,0.00532134873443888,-0.0220627704632104,-0.00120308342421003,0.0288269239967747
ACTN2,Alpha-actinin-2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37562,-0.00664157340261993,0.00542676763848004,-0.0172780379740408,0.00399489116880095,0.221029156089732
ACTN2,Alpha-actinin-2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37562,-0.020487547622311,0.00527566404846587,-0.0308278491573041,-0.0101472460873179,0.000103508748770702
ACTN2,Alpha-actinin-2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37562,-0.0202780541978654,0.00528542697979885,-0.0306374910782711,-0.00991861731745964,0.000125335730008905
ACTN2,Alpha-actinin-2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37562,-0.019166698606478,0.00524989932470165,-0.0294565012828933,-0.00887689593006278,0.000262370297517352
ACTN2,Alpha-actinin-2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37562,-0.0216413399824137,0.00510065796098416,-0.0316386295859427,-0.0116440503788848,2.22212694824717e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37562,-0.0228212756677508,0.00499496342390156,-0.0326114039785978,-0.0130311473569037,4.94864427650756e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37562,-0.0189650680692131,0.00520983625841948,-0.0291763471357152,-0.00875378900271087,0.000273429137797377
ACTN2,Alpha-actinin-2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37562,-0.0193167126221044,0.00534719140657469,-0.0297972077789908,-0.00883621746521797,0.000304396374070073
ACTN2,Alpha-actinin-2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37562,-0.0215911919423743,0.00522932769291388,-0.0318406742204855,-0.0113417096642631,3.6681494085309e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37562,-0.0224159427849696,0.00521698153059515,-0.0326412265849361,-0.0121906589850031,1.74588587153341e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37562,-0.0221444393108433,0.00519142533004411,-0.0323196329577298,-0.0119692456639569,2.00781793287741e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37562,-0.021714696193536,0.00504697242618516,-0.0316067621488589,-0.0118226302382131,1.70090754249007e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37562,-0.0202349843711376,0.00492786192166518,-0.0298935937376013,-0.0105763750046738,4.04590460591493e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37562,-0.0228351755849749,0.00517189492096994,-0.032972089630076,-0.0126982615398739,1.01703625033877e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37562,-0.0221164011339684,0.00529624261722199,-0.0324970366637235,-0.0117357656042133,2.98773574210223e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37562,-0.0206441446730465,0.00496307300115522,-0.0303717677553107,-0.0109165215907822,3.20908110286992e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37562,-0.0212548383935113,0.00501546903595572,-0.0310851577039845,-0.011424519083038,2.27207337850931e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37562,-0.0196627773612453,0.00495126867700075,-0.0293672639681668,-0.00995829075432383,7.18752919540173e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37562,-0.017524912926672,0.00498297126341646,-0.0272915366029682,-0.00775828925037573,0.000437994897490573
ACTN2,Alpha-actinin-2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37562,-0.0157179113222435,0.00506503204691093,-0.025645374134189,-0.00579044851029812,0.00191834103107447
ACTN2,Alpha-actinin-2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37562,-0.0191005166599006,0.00493711661988775,-0.0287772652348806,-0.00942376808492065,0.000109919786042844
ACTN2,Alpha-actinin-2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37562,-0.0219256780353793,0.00519766561134407,-0.0321131026336137,-0.0117382534371449,2.47728245328138e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37562,-0.0172610510377084,0.00499926786688548,-0.0270596160568039,-0.00746248601861284,0.000556725306149208
ACTN2,Alpha-actinin-2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37562,-0.0181621376767415,0.00497108156274769,-0.0279054575397269,-0.008418817813756,0.000259639473826953
ACTN2,Alpha-actinin-2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37562,-0.0188353410353071,0.00491153582908367,-0.028461951260311,-0.00920873081030306,0.000126193706093577
ACTN2,Alpha-actinin-2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37562,-0.0187211123383865,0.00485270223890309,-0.0282324087266366,-0.00920981595013644,0.000114925289171996
ACTN2,Alpha-actinin-2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37562,-0.0183712541687106,0.00482354870481211,-0.0278254096301423,-0.00891709870727883,0.000140359506570053
ACTN2,Alpha-actinin-2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37562,-0.0190863794523635,0.00491893767470202,-0.0287274972947794,-0.0094452616099475,0.000104888508987183
ACTN2,Alpha-actinin-2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37562,-0.014681485533159,0.00514566675703273,-0.0247669923769432,-0.00459597868937487,0.00433526065480215
ACTN2,Alpha-actinin-2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37562,-0.00852601627707875,0.00502618705719977,-0.0183773429091903,0.00132531035503279,0.0898492371688835
ACTN2,Alpha-actinin-2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37562,-0.00626765497675148,0.0050243179459818,-0.0161153181508758,0.00358000819737284,0.212249752404403
ACTN2,Alpha-actinin-2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37562,-0.00438245519742449,0.00501398481126944,-0.0142098654275126,0.00544495503266362,0.382109014984823
ACTN2,Alpha-actinin-2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37562,-0.00717744681150556,0.00510969074779996,-0.0171924406771935,0.00283754705418235,0.160142103128247
ACTN2,Alpha-actinin-2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37562,-0.00715646173563612,0.00514734014194862,-0.0172452484138554,0.00293232494258318,0.164454634202481
ACTN2,Alpha-actinin-2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37562,-0.00713407111673266,0.00503482697005732,-0.017002331978045,0.00273418974457969,0.156522874344581
ACTN2,Alpha-actinin-2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37562,-0.00483262925817592,0.00510979231632941,-0.0148478221981816,0.00518256368182972,0.344289233132759
ACTN2,Alpha-actinin-2,NMR metabolomics,X23523.Concentration of IDL Particles,37562,-0.0130879704542773,0.00504869252588353,-0.0229834078050091,-0.00319253310354562,0.00954289402466944
ACTN2,Alpha-actinin-2,NMR metabolomics,X23524.Total Lipids in IDL,37562,-0.0112001918736889,0.00518785990903106,-0.0213683972953897,-0.00103198645198799,0.0308741994683657
ACTN2,Alpha-actinin-2,NMR metabolomics,X23525.Phospholipids in IDL,37562,-0.00963844803756278,0.00520015377717265,-0.0198307494408212,0.000553853365695625,0.0638341946509697
ACTN2,Alpha-actinin-2,NMR metabolomics,X23526.Cholesterol in IDL,37562,-0.0120240362033503,0.0051951632183574,-0.0222065561113308,-0.00184151629536984,0.0206574691193392
ACTN2,Alpha-actinin-2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37562,-0.012259926506669,0.00518725548948234,-0.0224269472660544,-0.00209290574728364,0.0181191620428258
ACTN2,Alpha-actinin-2,NMR metabolomics,X23528.Free Cholesterol in IDL,37562,-0.0111639465938952,0.00521004632136395,-0.0213756373837685,-0.000952255804021852,0.032149686421433
ACTN2,Alpha-actinin-2,NMR metabolomics,X23529.Triglycerides in IDL,37562,-0.00152190494963812,0.00518769138349262,-0.0116897800612837,0.00864597016200742,0.769245186400021
ACTN2,Alpha-actinin-2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37562,-0.0137689725675507,0.00500284851353025,-0.02357455565407,-0.00396338948103142,0.00592729284939693
ACTN2,Alpha-actinin-2,NMR metabolomics,X23531.Total Lipids in Large LDL,37562,-0.018311210406926,0.00505656206478875,-0.0282220720539119,-0.00840034875994001,0.000294258686142381
ACTN2,Alpha-actinin-2,NMR metabolomics,X23532.Phospholipids in Large LDL,37562,-0.020679402330674,0.0050306861769375,-0.0305395472374715,-0.0108192574238765,3.96945415963821e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23533.Cholesterol in Large LDL,37562,-0.0181648426874684,0.00507186372941126,-0.0281056955971145,-0.00822398977782235,0.000342873306425231
ACTN2,Alpha-actinin-2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37562,-0.0185186144330864,0.00505077700659927,-0.0284181373660209,-0.00861909150015183,0.000246876126542092
ACTN2,Alpha-actinin-2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37562,-0.0165870254020927,0.00512405174553271,-0.0266301668233368,-0.0065438839808486,0.00121054660542478
ACTN2,Alpha-actinin-2,NMR metabolomics,X23536.Triglycerides in Large LDL,37562,-0.00337652831485198,0.00526548713061726,-0.0136968830908618,0.00694382646115785,0.521367198823602
ACTN2,Alpha-actinin-2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37562,-0.0253645251700477,0.00495392733559452,-0.0350742227478129,-0.0156548275922824,3.09727222859319e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37562,-0.02489345882466,0.00498013559441419,-0.0346545245897118,-0.0151323930596082,5.85086086328883e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37562,-0.0235292432945962,0.00494421927950058,-0.0332199130824173,-0.013838573506775,1.96689716899182e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37562,-0.0259032144234399,0.00497924266547306,-0.0356625300477671,-0.0161438987991127,1.99869518628361e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37562,-0.0267542714168411,0.00499686040954074,-0.0365481178195409,-0.0169604250141413,8.73773759686614e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37562,-0.0223380505344959,0.00498323217742779,-0.0321051856022544,-0.0125709154667374,7.43493970198081e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37562,-0.00684984971499623,0.00534182761226668,-0.0173198318350389,0.00362013240504647,0.19975851481665
ACTN2,Alpha-actinin-2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37562,-0.0184816566538409,0.00494374524704636,-0.0281713973380518,-0.00879191596963005,0.000185988600861122
ACTN2,Alpha-actinin-2,NMR metabolomics,X23545.Total Lipids in Small LDL,37562,-0.0198516808825081,0.00499181425176197,-0.0296356368159616,-0.0100677249490547,7.02101570719586e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23546.Phospholipids in Small LDL,37562,-0.0147284043069402,0.00497046288205941,-0.0244705115557766,-0.00498629705810373,0.00305019815595727
ACTN2,Alpha-actinin-2,NMR metabolomics,X23547.Cholesterol in Small LDL,37562,-0.0220576264756708,0.00497523946506122,-0.0318090958271908,-0.0123061571241508,9.34776693185999e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37562,-0.0224469488744052,0.00500873716486751,-0.0322640737175455,-0.0126298240312649,7.47276678625235e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37562,-0.0192026046163384,0.0049492972268337,-0.0289032271809324,-0.00950198205174435,0.000105025710930579
ACTN2,Alpha-actinin-2,NMR metabolomics,X23550.Triglycerides in Small LDL,37562,-0.00871076806563576,0.00538072142979541,-0.0192569820680348,0.00183544593676324,0.105496109161063
ACTN2,Alpha-actinin-2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37562,0.032609011653565,0.00577917332059465,0.0212818319451995,0.0439361913619305,1.71064582208948e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37562,0.0369112395469623,0.00580847681630507,0.0255266249870044,0.0482958541069202,2.15717296790567e-10
ACTN2,Alpha-actinin-2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37562,0.039287076512138,0.0058069614447706,0.0279054320803877,0.0506687209438884,1.38477753126589e-11
ACTN2,Alpha-actinin-2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37562,0.0334567203550119,0.00577401000278448,0.0221396607495543,0.0447737799604694,7.01564311149654e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37562,0.033919759849543,0.00586924554661152,0.0224160385781844,0.0454234811209016,7.6747277517181e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37562,0.0304835389703813,0.00536980978509812,0.019958711791589,0.0410083661491736,1.40117127555805e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37562,0.00769763399243857,0.00520580878417477,-0.00250575122454398,0.0179010192094211,0.139254576904483
ACTN2,Alpha-actinin-2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37562,0.0308988067490018,0.00611997490894789,0.018903655927464,0.0428939575705397,4.50453884759469e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23559.Total Lipids in Large HDL,37562,0.032022025881193,0.00608569680505056,0.0200940601432939,0.0439499916190921,1.44860480750121e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23560.Phospholipids in Large HDL,37562,0.0310183710727112,0.00600421697066386,0.01925010581021,0.0427866363352123,2.42539323971235e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23561.Cholesterol in Large HDL,37562,0.0326158799863804,0.00608958666628906,0.0206802901204539,0.044551469852307,8.65172784463834e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37562,0.032191396429909,0.00607124388892998,0.0202917584076062,0.0440910344522117,1.16226330688306e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37562,0.0334630466738778,0.0060808474667791,0.0215445856389907,0.0453815077087648,3.8034147353932e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23564.Triglycerides in Large HDL,37562,0.00749865876670075,0.0051263106548678,-0.00254891011684014,0.0175462276502416,0.143551876245521
ACTN2,Alpha-actinin-2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37562,0.00464614566950174,0.00545223677521495,-0.00604023840991957,0.015332529748923,0.394144160453869
ACTN2,Alpha-actinin-2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37562,0.00398713783755421,0.00540164897189192,-0.00660009414735395,0.0145743698224624,0.460446565864459
ACTN2,Alpha-actinin-2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37562,0.00322256327169794,0.00536466853049445,-0.00729218704807119,0.0137373135914671,0.548049348453494
ACTN2,Alpha-actinin-2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37562,0.0061589632786201,0.00547681587037098,-0.00457559582730702,0.0168935223845472,0.260799587037179
ACTN2,Alpha-actinin-2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37562,0.00575181030296043,0.00544952579318865,-0.00492926025168933,0.0164328808576102,0.291229930451853
ACTN2,Alpha-actinin-2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37562,0.0076674795933917,0.0055464399402325,-0.00320354268946401,0.0185385018762474,0.166867982648448
ACTN2,Alpha-actinin-2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37562,-0.0105638472578998,0.00495333568049942,-0.0202723851916786,-0.000855309324120899,0.0329700514642862
ACTN2,Alpha-actinin-2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37562,-0.0283557985518667,0.0048948981148839,-0.0379497988570391,-0.0187617982466942,7.0757422879674e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23573.Total Lipids in Small HDL,37562,-0.0243501760042328,0.00494363264584999,-0.0340396959900988,-0.0146606560183668,8.51433984731868e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23574.Phospholipids in Small HDL,37562,-0.0209272079218132,0.00499359523675337,-0.0307146545858498,-0.0111397612577766,2.79782504488151e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23575.Cholesterol in Small HDL,37562,-0.0262580525487009,0.00490652864989273,-0.0358748487024907,-0.0166412563949112,8.86203219140822e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37562,-0.027912014640477,0.00485271646437964,-0.0374233389106611,-0.0184006903702929,9.02520692967071e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37562,-0.0172647060855231,0.00509452731973554,-0.0272499796322048,-0.00727943253884149,0.000703871762826439
ACTN2,Alpha-actinin-2,NMR metabolomics,X23578.Triglycerides in Small HDL,37562,-0.0192998898387478,0.00512304266374728,-0.0293410534596925,-0.00925872621780315,0.00016576419218159
ACTN2,Alpha-actinin-2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,-0.00363780388263847,0.00468006748333546,-0.012810736149976,0.00553512838469905,0.436998214015932
ACTN2,Alpha-actinin-2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,-0.0122829144924473,0.00489409404026483,-0.0218753388113664,-0.00269049017352822,0.0120945745035614
ACTN2,Alpha-actinin-2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,-0.014435048889866,0.00477211275490258,-0.0237883898894751,-0.00508170789025698,0.00249244692013622
ACTN2,Alpha-actinin-2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,-0.00259970406017788,0.00498999068952667,-0.0123800858116502,0.00718067769129439,0.602387398639467
ACTN2,Alpha-actinin-2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36847,0.0143100131793975,0.00473831267576688,0.00502292033489437,0.0235971060239005,0.00253234973822351
ACTN2,Alpha-actinin-2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37362,-0.00115620839851302,0.0046000590460426,-0.0101723241287565,0.00785990733173049,0.801550284962025
ACTN2,Alpha-actinin-2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37362,0.00396823072600705,0.00524944071745214,-0.00632067308019914,0.0142571345322132,0.449702559347199
ACTN2,Alpha-actinin-2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37362,0.00256663360255135,0.00526344575230745,-0.00774972007197126,0.012882987277074,0.625817591088805
ACTN2,Alpha-actinin-2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37362,0.00938346258137383,0.00495685139947465,-0.000331966161596494,0.0190988913243441,0.0583763803162922
ACTN2,Alpha-actinin-2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37362,-0.00175521639874548,0.00503415551679004,-0.011622161211654,0.008111728414163,0.727349109144011
ACTN2,Alpha-actinin-2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37557,-0.0090241861144165,0.00491442157464175,-0.0186564524007143,0.000608080171881327,0.066340938623715
ACTN2,Alpha-actinin-2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37557,-0.000494540504087866,0.00482662055358714,-0.00995471678911866,0.00896563578094293,0.91839231275051
ACTN2,Alpha-actinin-2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37557,0.0043643360725671,0.00506879308240849,-0.00557049836895353,0.0142991705140877,0.389242361933181
ACTN2,Alpha-actinin-2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37557,-0.00755011563484813,0.00464053242738132,-0.0166455591925155,0.00154532792281926,0.103762540904735
ACTN2,Alpha-actinin-2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37557,0.00614038499184257,0.00455390273406115,-0.00278526436691728,0.0150660343506024,0.177559946096775
ACTN2,Alpha-actinin-2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37562,0.00262523568135445,0.00510808176236966,-0.00738660457289009,0.012637075935599,0.607304225657397
ACTN2,Alpha-actinin-2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37562,0.00749908741881322,0.00534014409754315,-0.00296759501237136,0.0179657698499978,0.160257512374122
ACTN2,Alpha-actinin-2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37562,0.00788047169777993,0.00538370864246876,-0.00267159724145884,0.0184325406370187,0.14328278304921
ACTN2,Alpha-actinin-2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37562,0.00529297924505323,0.00521565584312461,-0.00492970620747102,0.0155156646975775,0.310207863369597
ACTN2,Alpha-actinin-2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37562,-0.00654448225952186,0.00530097636541769,-0.0169343959357405,0.00384543141669681,0.217008783112782
ACTN2,Alpha-actinin-2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37562,-0.00184346631873758,0.0051999103318387,-0.0120352905691414,0.00834835793166626,0.722955769397179
ACTN2,Alpha-actinin-2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37562,-0.00538215166043784,0.00506749301917948,-0.0153144379780296,0.00455013465715394,0.288212781176241
ACTN2,Alpha-actinin-2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37562,-0.00714417257142717,0.0049244936381476,-0.0167961801021965,0.00250783495934212,0.146875481026888
ACTN2,Alpha-actinin-2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37562,-0.00190505513349173,0.0052152583197801,-0.0121269614402607,0.00831685117327727,0.714904638893111
ACTN2,Alpha-actinin-2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37562,0.00443917159965479,0.00511412969027769,-0.00558452259328949,0.0144628657925991,0.385398764484668
ACTN2,Alpha-actinin-2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37562,0.0146113596154942,0.00520750500479216,0.00440464980610162,0.0248180694248869,0.00502615492299417
ACTN2,Alpha-actinin-2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37562,-0.00349814776600218,0.00540310039401258,-0.0140882245382668,0.00709192900626247,0.51736280884187
ACTN2,Alpha-actinin-2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37562,-0.0027714546367078,0.00544219336385107,-0.0134381536298559,0.0078952443564403,0.610583296047702
ACTN2,Alpha-actinin-2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37562,-0.00807811924517138,0.00525845537044841,-0.0183846917712503,0.00222845328090751,0.124509733360694
ACTN2,Alpha-actinin-2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37562,0.000489512172398241,0.00538908467245696,-0.0100730937856174,0.0110521181304139,0.927625873181493
ACTN2,Alpha-actinin-2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37562,0.0108038040157442,0.00488844129930108,0.00122245906911407,0.0203851489623743,0.0271174217180057
ACTN2,Alpha-actinin-2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37562,-0.0101357107936123,0.00516938890104705,-0.0202677130396645,-3.70854756007177e-06,0.0499331393631666
ACTN2,Alpha-actinin-2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37562,-0.0107519222456094,0.00517179408198945,-0.0208886386463088,-0.000615205844910101,0.0376409697635621
ACTN2,Alpha-actinin-2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37562,-0.00243150267716189,0.00526561411416887,-0.0127521063409329,0.00788910098660909,0.644253922058271
ACTN2,Alpha-actinin-2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37562,0.00837416700343544,0.00532535792177659,-0.00206353452324668,0.0188118685301176,0.115856957377299
ACTN2,Alpha-actinin-2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37562,-0.0138963596536397,0.00487485290743383,-0.0234510713522101,-0.00434164795506943,0.00437019957993349
ACTN2,Alpha-actinin-2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37562,-0.00717488748055254,0.00535456100040147,-0.0176698270413394,0.00332005208023435,0.180282185346775
ACTN2,Alpha-actinin-2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37562,-0.0117681677830179,0.00492851383937989,-0.0214280549082025,-0.00210828065783331,0.0169649249909311
ACTN2,Alpha-actinin-2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37562,0.00504430398604361,0.00533045544507872,-0.00540338868631067,0.0154919966583979,0.344004042843295
ACTN2,Alpha-actinin-2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37562,0.0154374065489003,0.0053064636037757,0.00503673788549997,0.0258380752123007,0.00362998177018977
ACTN2,Alpha-actinin-2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37562,0.0130028873709641,0.004811202459007,0.00357293055131036,0.0224328441906178,0.0068882418009182
ACTN2,Alpha-actinin-2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37562,-0.0251150712141578,0.00493753056901424,-0.0347926311294258,-0.0154375112988899,3.69643251776779e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37562,-0.0268400736126101,0.00502001486173299,-0.0366793027416068,-0.0170008444836135,9.11188382639257e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37562,0.00873169858247305,0.00544201465817426,-0.0019346501475485,0.0193980473124946,0.108628535921221
ACTN2,Alpha-actinin-2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37562,0.0204386911428659,0.0051193125587847,0.0104048385276479,0.0304725437580839,6.57456184982522e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37562,0.0249906268087913,0.00490759325073961,0.0153717440373417,0.0346095095802409,3.58773467824416e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37562,-0.0283625593054734,0.00495896046666309,-0.0380821218201331,-0.0186429967908138,1.09198954227103e-08
ACTN2,Alpha-actinin-2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37562,-0.0235247707617995,0.00495702100189709,-0.0332405319255178,-0.0138090095980812,2.09931580463827e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37562,-0.00402782554200434,0.00531221376001407,-0.0144397645116319,0.00638411342762323,0.44833305201154
ACTN2,Alpha-actinin-2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37562,0.00743118443858441,0.00524243624144246,-0.0028439905946428,0.0177063594718116,0.156358828381268
ACTN2,Alpha-actinin-2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37560,0.0400774326882468,0.0056464158409344,0.0290104576400153,0.0511444077364782,1.33230564188785e-12
ACTN2,Alpha-actinin-2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37560,-0.0339092733800184,0.00564247167119858,-0.0449685178555676,-0.0228500289044692,1.90859624927995e-09
ACTN2,Alpha-actinin-2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37560,-0.0224533815479167,0.0056574792767506,-0.0335420409303479,-0.0113647221654856,7.2621707191919e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37560,-0.0309400926150183,0.00601221621871998,-0.0427240364037095,-0.0191561488263272,2.69652794156006e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37560,-0.0253591943214967,0.00563147522644064,-0.0363968857653204,-0.0143215028776731,6.75418059980418e-06
ACTN2,Alpha-actinin-2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37562,-0.0167939636539221,0.00585229843413975,-0.028264468584836,-0.00532345872300818,0.00411602107855627
ACTN2,Alpha-actinin-2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37562,0.0234520633684267,0.00582507485201052,0.0120349166584861,0.0348692100783674,5.70399439171578e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37562,0.018231105158409,0.00587781020359641,0.00671059715936006,0.029751613157458,0.00192832293689902
ACTN2,Alpha-actinin-2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37562,0.0285920595629282,0.00565806416713856,0.0175022537953366,0.0396818653305198,4.40022288810844e-07
ACTN2,Alpha-actinin-2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37562,-0.019951631700504,0.00566809061674991,-0.0310610893093339,-0.00884217409167419,0.000433024407637872
ACTN2,Alpha-actinin-2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37562,-0.00902752197885669,0.00552379616094476,-0.0198541624543084,0.00179911849659505,0.102220571123265
ACTN2,Alpha-actinin-2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37562,0.0122942649040529,0.0053949248224461,0.00172021225205856,0.0228683175560472,0.0226915428202072
ACTN2,Alpha-actinin-2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37562,0.00929869358917943,0.00535523434256021,-0.00119756572223858,0.0197949529005974,0.0825210886667019
ACTN2,Alpha-actinin-2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37562,0.0173627353027603,0.00581513057317201,0.00596507937934312,0.0287603912261774,0.00283372911137624
ACTN2,Alpha-actinin-2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37562,-0.0135983404118351,0.00525360461643348,-0.0238954054600447,-0.00330127536362548,0.00965341507688963
ACTN2,Alpha-actinin-2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37562,0.0224005579357134,0.0051007809154435,0.0124030273414442,0.0323980885299827,1.13404736339605e-05
ACTN2,Alpha-actinin-2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37562,-0.00857062742856322,0.0051245953053511,-0.0186148342270514,0.00147357936992494,0.0944595576557416
ACTN2,Alpha-actinin-2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37562,-0.0147462292479124,0.00514197648227867,-0.0248245031531786,-0.00466795534264625,0.00413978412059678
ACTN2,Alpha-actinin-2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37562,0.0185403609094262,0.00526486590862319,0.00822122372852477,0.0288594980903277,0.000430528947480191
ACTN2,Alpha-actinin-2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37562,-0.0108186563529968,0.00525579613207455,-0.0211200167718629,-0.000517295934130651,0.0395691771074203
ACTN2,Alpha-actinin-2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47544,-0.00417654833832526,0.00422953532142453,-0.0124664375683173,0.00411334089166683,0.32342157558043
ACTN2,Alpha-actinin-2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47544,-0.0041944698926431,0.00414611726980429,-0.0123208597414595,0.00393191995617331,0.311710220826915
ACTN2,Alpha-actinin-2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45877,0.000441063880005656,0.00395932082808318,-0.00731920494303737,0.00820133270304868,0.911301096848449
ACTN2,Alpha-actinin-2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45877,-0.00486307616077251,0.00432628583123422,-0.0133425963899916,0.00361644406844656,0.260993175028429
ACTN2,Alpha-actinin-2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45877,-0.000725480420725609,0.00422992451025201,-0.00901613246081954,0.00756517161936832,0.863823259969815
ACTN2,Alpha-actinin-2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45877,-0.00105905817560157,0.00388559607434692,-0.00867482648132153,0.00655671013011838,0.785194068426725
ACTN2,Alpha-actinin-2,Working and living environment,X24009.Traffic intensity on the nearest road,47544,0.0240716461035607,0.0484111878845544,-0.0708142821501659,0.118957574357287,0.619029400977733
ACTN2,Alpha-actinin-2,Working and living environment,X24010.Inverse distance to the nearest road,47544,0.0053904217979027,0.00370932075830487,-0.00187984688837485,0.0126606904841803,0.146179061876578
ACTN2,Alpha-actinin-2,Working and living environment,X24011.Traffic intensity on the nearest major road,47544,0.00385072417684207,0.00371045336336395,-0.00342176441535128,0.0111232127690354,0.299372076184998
ACTN2,Alpha-actinin-2,Working and living environment,X24012.Inverse distance to the nearest major road,47544,-0.00327641444613656,0.00378459500287136,-0.0106942206517644,0.0041413917594913,0.386650569754244
ACTN2,Alpha-actinin-2,Working and living environment,X24013.Total traffic load on major roads,47544,-0.0241952543608052,0.0344507566181737,-0.0917187373324256,0.0433282286108153,0.482490340832642
ACTN2,Alpha-actinin-2,Working and living environment,X24015.Sum of road length of major roads within 100m,47544,-0.00974730715234555,0.0330850367360899,-0.0745939791550817,0.0550993648503906,0.768291596122598
ACTN2,Alpha-actinin-2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47544,0.000955161358892388,0.00421694750448199,-0.00731005574989231,0.00922037846767709,0.820810368752656
ACTN2,Alpha-actinin-2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47544,-5.43073348884885e-05,0.00420907934308943,-0.00830410284734378,0.0081954881775668,0.989705750555376
ACTN2,Alpha-actinin-2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47544,0.00197204009797102,0.00417136138019516,-0.00620382820721149,0.0101479084031535,0.636391056563075
ACTN2,Alpha-actinin-2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47489,0.00554806949178203,0.00409745168272369,-0.0024829358063564,0.0135790747899205,0.175740323315721
ACTN2,Alpha-actinin-2,Working and living environment,X24020.Average daytime sound level of noise pollution,47544,0.00129709219463348,0.00374035773594914,-0.00603400896782682,0.00862819335709379,0.72875756617383
ACTN2,Alpha-actinin-2,Working and living environment,X24021.Average evening sound level of noise pollution,47544,0.00126826832211657,0.00374046575839499,-0.0060630445643376,0.00859958120857074,0.734562377291582
ACTN2,Alpha-actinin-2,Working and living environment,X24022.Average night-time sound level of noise pollution,47544,0.00130338265563723,0.00374033533998273,-0.00602767461072892,0.00863443992200338,0.727492825982637
ACTN2,Alpha-actinin-2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47544,0.00130997658720704,0.00374034052567701,-0.00602109084311989,0.00864104401753397,0.726169865208112
ACTN2,Alpha-actinin-2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47544,0.00127657282586325,0.0037404507617344,-0.00605471066713616,0.00860785631886267,0.732889510475851
ACTN2,Alpha-actinin-2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44900,0.00273082137921059,0.00432471333210669,-0.00574561675171853,0.0112072595101397,0.5277562403816
ACTN2,Alpha-actinin-2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44900,0.00249624193356405,0.00394560181454631,-0.00523713762294671,0.0102296214900748,0.526959875436988
ACTN2,Alpha-actinin-2,Working and living environment,"X24502.Water percentage, buffer 1000m",44900,0.00310127326873308,0.00386536894144245,-0.00447484985649412,0.0106773963939603,0.422375635668884
ACTN2,Alpha-actinin-2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44900,0.000936260156261899,0.0040781303240806,-0.00705687527893608,0.00892939559145988,0.818419874751162
ACTN2,Alpha-actinin-2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44900,0.00254184672553146,0.0039833792116322,-0.00526557652926764,0.0103492699803306,0.523407161663271
ACTN2,Alpha-actinin-2,Working and living environment,"X24505.Water percentage, buffer 300m",44900,0.00672402622893862,0.0039002414488023,-0.000920447010713897,0.0143684994685911,0.0847224961676932
ACTN2,Alpha-actinin-2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47686,0.0016828551536726,0.00413141008418037,-0.00641470861132092,0.00978041891866612,0.683767983003874
ACTN2,Alpha-actinin-2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47686,-0.00292709411129891,0.00390273231169962,-0.0105764494422302,0.00472226121963235,0.453255373668801
ACTN2,Alpha-actinin-2,Working and living environment,X24508.Distance (Euclidean) to coast,47686,0.00889039300258434,0.00371194287743516,0.00161498496281143,0.0161658010423573,0.0166246950770579
ACTN2,Alpha-actinin-2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,33920,-0.031262919589061,0.0355669623642479,-0.100974165822987,0.0384483266448648,0.379430297687891
ACTN2,Alpha-actinin-2,Health and medical history,X2704.Years since last cervical smear test,42265,-0.0525788841514781,0.0258783832490055,-0.103300515319529,-0.00185725298342745,0.0421919084292364
ACTN2,Alpha-actinin-2,Health and medical history,X2714.Age when periods started (menarche),47116,-0.0170740504368837,0.0222486848399777,-0.06068147272324,0.0265333718494727,0.442840778546636
ACTN2,Alpha-actinin-2,Health and medical history,X2734.Number of live births,47824,-0.00118606081427681,0.0213584539575754,-0.0430486305711245,0.0406765089425709,0.95571574031448
ACTN2,Alpha-actinin-2,Health and medical history,X2744.Birth weight of first child,43044,0.022782223123833,0.0236926021356764,-0.0236552770620927,0.0692197233097587,0.336275450348724
ACTN2,Alpha-actinin-2,Health and medical history,X2754.Age at first live birth,40263,0.00586448320188863,0.0047309334256354,-0.00340814631235676,0.015137112716134,0.215140361078557
ACTN2,Alpha-actinin-2,Health and medical history,X2764.Age at last live birth,40215,0.0135634711059922,0.00456590228207326,0.00461430263312866,0.0225126395788558,0.0029766632633533
ACTN2,Alpha-actinin-2,Health and medical history,X2794.Age started oral contraceptive pill,42342,-0.00310487922268453,0.00513845936487966,-0.0131762595778487,0.0069665011324796,0.545689613749592
ACTN2,Alpha-actinin-2,Health and medical history,X2804.Age when last used oral contraceptive pill,40672,-0.00235241670074582,0.00443222600551853,-0.0110395796715621,0.0063347462700705,0.595597305793583
ACTN2,Alpha-actinin-2,Lifestyle factors,X2867.Age started smoking in former smokers,29227,0.00722018292505578,0.00838110924156,-0.00920679118840182,0.0236471570385134,0.389015351450909
ACTN2,Alpha-actinin-2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",33612,0.0319272042208667,0.0398353674900803,-0.0461501160596907,0.110004524501424,0.422875282103313
ACTN2,Alpha-actinin-2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,33606,0.00119098485711422,0.0432222940287545,-0.0835247114392446,0.085906681153473,0.978017774267665
ACTN2,Alpha-actinin-2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,33635,-0.0189644392498245,0.0477203842548658,-0.112496392389362,0.0745675138897125,0.69107621441447
ACTN2,Alpha-actinin-2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",33594,0.0131604605638527,0.0451457411422158,-0.0753251920748902,0.101646113202596,0.770667479236408
ACTN2,Alpha-actinin-2,Mental health,X28739.Difficulty with standing for long periods,33650,0.0464023868028667,0.0395084568891581,-0.0310341886998832,0.123838962305617,0.240228225017893
ACTN2,Alpha-actinin-2,Mental health,X28740.Difficulty with taking care of household responsibilities,33674,0.0531458938324969,0.0431990173217446,-0.0315241801181224,0.137815967783116,0.218632268727162
ACTN2,Alpha-actinin-2,Mental health,X28741.Difficulty learning a new task,33577,0.0852296442461131,0.0471283961331403,-0.00714201217484188,0.177601300667068,0.0705684299244413
ACTN2,Alpha-actinin-2,Mental health,X28742.Difficulty with joining in community activities,33344,0.0493467051429966,0.050860765369472,-0.0503403949811684,0.149033805267162,0.331957624390897
ACTN2,Alpha-actinin-2,Mental health,X28743.Difficulty with being emotionally affected by health problems,33610,0.0492410550593996,0.0420206690783185,-0.0331194563341047,0.131601566452904,0.241296054546951
ACTN2,Alpha-actinin-2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,33664,0.0406430653040841,0.0621333332450931,-0.0811382678562983,0.162424398464467,0.513046587103172
ACTN2,Alpha-actinin-2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29206,-0.00409888215423179,0.0507558681131737,-0.103580383656052,0.0953826193475887,0.935638754066599
ACTN2,Alpha-actinin-2,Lifestyle factors,X2897.Age stopped smoking,29234,-0.0208449202166298,0.00859389878536372,-0.0376889618359428,-0.00400087859731695,0.0153220285437559
ACTN2,Alpha-actinin-2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,32730,-0.00327449638383071,0.0127112568528664,-0.0281885598154489,0.0216395670477874,0.796717380537261
ACTN2,Alpha-actinin-2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,32730,-0.00972541489110737,0.0135446534951047,-0.0362729357415127,0.0168221059592979,0.472761449526248
ACTN2,Alpha-actinin-2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,32730,-0.000467278853952539,0.0457217608666037,-0.0900819301524958,0.0891473724445907,0.991845965125234
ACTN2,Alpha-actinin-2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,32730,-0.0715225731211585,0.0487624862791888,-0.167097046228368,0.0240518999860516,0.142480967007297
ACTN2,Alpha-actinin-2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,32730,0.0356818385887041,0.0499359256926935,-0.0621925757689751,0.133556252946383,0.474905777733642
ACTN2,Alpha-actinin-2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,32730,0.0302259566546145,0.0407206901324633,-0.0495865960050136,0.110038509314243,0.457941701207931
ACTN2,Alpha-actinin-2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,32730,-0.0119551271555858,0.0192523555297643,-0.0496897439939238,0.0257794896827522,0.534636734613913
ACTN2,Alpha-actinin-2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,32730,0.0129847359191327,0.0333899988625087,-0.0524596618513843,0.0784291336896496,0.697374184950065
ACTN2,Alpha-actinin-2,Mental health,X29002.Recent lack of interest or pleasure in doing things,32676,-0.121783775309401,0.0486723245076123,-0.217181531344321,-0.0263860192744811,0.0123646341305648
ACTN2,Alpha-actinin-2,Mental health,X29003.Recent feelings of depression,32663,-0.0201003170795934,0.0448394432881655,-0.107985625924398,0.0677849917652111,0.653967929284153
ACTN2,Alpha-actinin-2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32682,-0.0406069636018722,0.0369444448282506,-0.113018075465243,0.0318041482614988,0.271740976031377
ACTN2,Alpha-actinin-2,Mental health,X29005.Recent feelings of tiredness or low energy,32690,-0.0461010236307487,0.0373185058330739,-0.119245295063573,0.0270432478020761,0.216739422922378
ACTN2,Alpha-actinin-2,Mental health,X29006.Recent poor appetite or overeating,32694,0.0312736530054952,0.047668055651298,-0.062155736071049,0.124703042082039,0.511796436404925
ACTN2,Alpha-actinin-2,Mental health,X29007.Recent feelings of inadequacy,32651,0.0303277419710798,0.0479568302457709,-0.0636676453106311,0.124323129252791,0.527145317861568
ACTN2,Alpha-actinin-2,Mental health,X29008.Recent trouble concentrating on things,32692,0.0449073854864015,0.0483060595073651,-0.0497724911480341,0.139587262120837,0.352583244448318
ACTN2,Alpha-actinin-2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32681,-0.0034976275277524,0.0882557404999701,-0.176478878907694,0.169483623852189,0.968388596752209
ACTN2,Alpha-actinin-2,Mental health,X29010.Recent thoughts of suicide or self-harm,32623,0.0543762875376044,0.0948284125313812,-0.131487401023903,0.240239976099112,0.566377712436007
ACTN2,Alpha-actinin-2,Mental health,X29038#0.Substances taken for depression_None of options listed,31791,-0.0133584788147059,0.0239338162996442,-0.0602687587620086,0.0335518011325968,0.576764142725382
ACTN2,Alpha-actinin-2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31791,-0.0813294246994867,0.047031398764281,-0.173510966277478,0.0108521168785041,0.0838049721514914
ACTN2,Alpha-actinin-2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31791,-0.0405458267556707,0.0222743894446598,-0.0842036300672038,0.00311197655586247,0.0687557118093958
ACTN2,Alpha-actinin-2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31791,0.0257495687697235,0.0654254731999144,-0.102484358702109,0.153983496241556,0.69390923008943
ACTN2,Alpha-actinin-2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31791,-0.0193449168675371,0.0409586830937966,-0.0996239357313784,0.0609341019963041,0.636724433774518
ACTN2,Alpha-actinin-2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31791,-0.0506788536588221,0.042582575305427,-0.134140701257459,0.0327829939398149,0.234033305351079
ACTN2,Alpha-actinin-2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31791,-0.00446536717074643,0.0516302413928623,-0.105660640300757,0.0967299059592637,0.931081303084986
ACTN2,Alpha-actinin-2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31791,-0.0251601605214394,0.0553078012328189,-0.133563450937765,0.0832431298948857,0.649186290871599
ACTN2,Alpha-actinin-2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31791,-0.0365909172826389,0.0422426898771115,-0.119386589441778,0.0462047548764997,0.386404924900336
ACTN2,Alpha-actinin-2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31791,-0.0447967082875309,0.0239458032376091,-0.0917304826332448,0.00213706605818297,0.0614189450433317
ACTN2,Alpha-actinin-2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31791,-0.0555707728612639,0.0360180338666789,-0.126166119239955,0.0150245735174267,0.12290793612161
ACTN2,Alpha-actinin-2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31791,-0.0531832635491001,0.057050777676527,-0.165002787795093,0.0586362606968929,0.351259053621723
ACTN2,Alpha-actinin-2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31791,-0.108093491518234,0.0754206719353551,-0.25591800851153,0.0397310254750615,0.151841072769458
ACTN2,Alpha-actinin-2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31791,-0.0515031410677561,0.0499996069203939,-0.149502370631728,0.0464960884962159,0.303010660600446
ACTN2,Alpha-actinin-2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31791,-0.182648868992597,0.0844286928405257,-0.348129106960027,-0.0171686310251667,0.030546393415525
ACTN2,Alpha-actinin-2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31791,-0.032049834652046,0.078333024439847,-0.185582562554146,0.121482893250054,0.68244267010832
ACTN2,Alpha-actinin-2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31791,-0.0456572696207569,0.041986658006269,-0.127951119313044,0.0366365800715304,0.276885495860266
ACTN2,Alpha-actinin-2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31791,-0.02837196436363,0.0410367088337595,-0.108803913677798,0.0520599849505386,0.489348567641658
ACTN2,Alpha-actinin-2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31791,-0.0284611215786753,0.0568055380264457,-0.139799976110509,0.0828777329531584,0.616366982843098
ACTN2,Alpha-actinin-2,Mental health,X29058.Recent feelings or nervousness or anxiety,32557,0.0201438177518642,0.0415779070963462,-0.0613488801569743,0.101636515660703,0.628055733440515
ACTN2,Alpha-actinin-2,Mental health,X29059.Recent inability to stop or control worrying,32568,-0.0201184068280417,0.0430344889800835,-0.104466005229005,0.0642291915729219,0.640158349608218
ACTN2,Alpha-actinin-2,Mental health,X29060.Recent worrying too much about different things,32561,-0.0233779701308143,0.0403730776461705,-0.102509202317308,0.0557532620556798,0.562572534630719
ACTN2,Alpha-actinin-2,Mental health,X29061.Recent trouble relaxing,32568,-0.0176126199662458,0.0424466722589854,-0.100808097593857,0.0655828576613657,0.678200284849997
ACTN2,Alpha-actinin-2,Mental health,X29062.Recent restlessness,32576,0.0178048791956871,0.0606309607338459,-0.101031803842651,0.136641562234025,0.769025336016978
ACTN2,Alpha-actinin-2,Mental health,X29063.Recent easy annoyance or irritability,32544,-0.0617768304712391,0.0451088476242878,-0.150190171814843,0.026636510872365,0.170879222117157
ACTN2,Alpha-actinin-2,Mental health,X29064.Recent feelings of foreboding,32533,0.00471847541013212,0.04814592258128,-0.0896475328491767,0.099084483669441,0.9219318383879
ACTN2,Alpha-actinin-2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31791,-0.0617132857266191,0.0238790976564675,-0.108516317133295,-0.0149102543199427,0.00977381690406042
ACTN2,Alpha-actinin-2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31791,-0.0389156552167162,0.0410218770822799,-0.119318534297985,0.0414872238645524,0.342826768648902
ACTN2,Alpha-actinin-2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31791,-0.129624103810427,0.0523857890707288,-0.232300250389055,-0.0269479572317981,0.0133679503042865
ACTN2,Alpha-actinin-2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31791,0.017820649854251,0.0579588575605946,-0.0957787109645143,0.131420010673016,0.758493854658859
ACTN2,Alpha-actinin-2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31791,-0.0206206988383033,0.0388280862868828,-0.0967237479605936,0.055482350283987,0.595381577599259
ACTN2,Alpha-actinin-2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31791,-0.00955453453980994,0.038858141745411,-0.0857164923608154,0.0666074232811956,0.805780116649277
ACTN2,Alpha-actinin-2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31791,-0.00399884128642336,0.0404100722648249,-0.0832025829254802,0.0752049003526335,0.92117547239978
ACTN2,Alpha-actinin-2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31791,-0.0673758319375237,0.0354682938016265,-0.136893687788712,0.00214202391366419,0.0575238313328127
ACTN2,Alpha-actinin-2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31791,-0.071487270067198,0.0482523957917718,-0.166061965819071,0.0230874256846748,0.138508890714439
ACTN2,Alpha-actinin-2,Mental health,X29076.Felt loved as a child,32542,-0.00808701063910056,0.0389376342540561,-0.0844047737770505,0.0682307524988494,0.835475185483698
ACTN2,Alpha-actinin-2,Mental health,X29077.Physically abused by family as a child,32559,0.146445534660566,0.0524263998366326,0.0436897909807658,0.249201278340365,0.00522868525507705
ACTN2,Alpha-actinin-2,Mental health,X29078.Felt hated by family member as a child,32538,-0.0318399949112485,0.0518475100464093,-0.133461114602211,0.0697811247797137,0.539160936808194
ACTN2,Alpha-actinin-2,Mental health,X29079.Sexually molested as a child,32452,0.0373528811877727,0.0635505231682177,-0.087206144221934,0.161911906597479,0.556705495497133
ACTN2,Alpha-actinin-2,Mental health,X29080.Someone to take to doctor when needed as a child,32522,-0.0325591765678614,0.0545863766712966,-0.139548474843603,0.07443012170788,0.550877531330141
ACTN2,Alpha-actinin-2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32535,-0.0151597632038095,0.0695979841435182,-0.151571812125105,0.121252285717486,0.827575640228817
ACTN2,Alpha-actinin-2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32472,-0.0798223132666758,0.052807546885047,-0.183325105161368,0.0236804786280163,0.130682646399291
ACTN2,Alpha-actinin-2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32538,0.0427416714060357,0.0570401424459996,-0.0690570077881235,0.154540350600195,0.453682439740718
ACTN2,Alpha-actinin-2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32500,0.0173655993519638,0.071999990265666,-0.123754381568741,0.158485580272669,0.809414848813822
ACTN2,Alpha-actinin-2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32508,0.00168948821993352,0.0715764305563525,-0.138600315670517,0.141979292110384,0.981169086759252
ACTN2,Alpha-actinin-2,Mental health,X29086.Experienced a violent or sexual assault,32536,0.0177365822295212,0.0667426954143131,-0.113079100782533,0.148552265241575,0.790441866415559
ACTN2,Alpha-actinin-2,Mental health,X29087.Experienced a life-threatening injury or illness,32549,0.00636481191060519,0.0471519848001518,-0.0860530782976923,0.0987827021189027,0.892627068842009
ACTN2,Alpha-actinin-2,Mental health,X29088.Experienced a marital separation or divorce,32550,-0.0429075565398129,0.0423193130079153,-0.125853410035327,0.0400382969557012,0.310660709590595
ACTN2,Alpha-actinin-2,Mental health,X29089.Experienced the death of a spouse or partner,32558,-0.0224939146473897,0.0539955678721023,-0.12832522767671,0.0833373983819308,0.67699069762947
ACTN2,Alpha-actinin-2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32546,0.0100821165403922,0.0531539575677228,-0.0940996402923444,0.114263873373129,0.84956651037744
ACTN2,Alpha-actinin-2,Lifestyle factors,X29091.Frequency of drinking alcohol,32554,-0.0641488070081363,0.0354225355676178,-0.133576976720667,0.00527936270439466,0.0701840263417086
ACTN2,Alpha-actinin-2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31497,-0.0960174393782831,0.0443744552846745,-0.182991371736245,-0.00904350702032114,0.0305132317867271
ACTN2,Alpha-actinin-2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31512,-0.0664062247917004,0.0447874518374112,-0.154189630393026,0.0213771808096254,0.138199560070204
ACTN2,Alpha-actinin-2,Mental health,X29104.Ever used cannabis,32549,0.0121661932763182,0.0554090394604824,-0.0964355240662274,0.120767910618864,0.826211166147762
ACTN2,Alpha-actinin-2,Mental health,X29108.Ever thought that life not worth living,32508,-0.0129402095831969,0.0427418303581945,-0.0967141970852582,0.0708337779188643,0.762086060370876
ACTN2,Alpha-actinin-2,Mental health,X29109.Ever contemplated self-harm,32533,0.00922489328075393,0.0561947185072455,-0.100916754993447,0.119366541554955,0.869609739489661
ACTN2,Alpha-actinin-2,Mental health,X29111.Ever self-harmed,32547,0.000404161311370903,0.0883230467628175,-0.172709010343751,0.173517332966493,0.996349050484417
ACTN2,Alpha-actinin-2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32539,0.0500064253516754,0.0584619027322274,-0.0645789040034903,0.164591754706841,0.392372943358823
ACTN2,Alpha-actinin-2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32377,0.055991778370633,0.0511246730184457,-0.0442125807455206,0.156196137486787,0.27346199571319
ACTN2,Alpha-actinin-2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32377,0.0212093190908911,0.0404275837797224,-0.0580287451173649,0.100447383299147,0.599858613150349
ACTN2,Alpha-actinin-2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32377,0.00949467654741407,0.0408665411150538,-0.0706037440380915,0.0895930971329196,0.816284803833303
ACTN2,Alpha-actinin-2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32377,0.0389710236344255,0.0522710296362403,-0.0634801944526054,0.141422241721456,0.455957275162722
ACTN2,Alpha-actinin-2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32534,0.0696729930918914,0.0392095708109568,-0.00717776569758387,0.146523751881367,0.0756159789171872
ACTN2,Alpha-actinin-2,Health and medical history,X29153.Pain or discomfort today,32546,0.0342404222673984,0.0372550697559179,-0.0387795144542006,0.107260358988997,0.358080667729417
ACTN2,Alpha-actinin-2,Mental health,X29154.Anxiety or depression today,32546,0.0204304906684074,0.0451436647854737,-0.068051092311121,0.108912073647936,0.65087337405925
ACTN2,Alpha-actinin-2,Mental health,X29166.Frequency of confiding in someone close,32341,0.00103559780976907,0.0360908357478302,-0.069702440255978,0.0717736358755162,0.977109205044991
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32519,0.00444310290498934,0.0136113009479553,-0.022235046953003,0.0311212527629817,0.744109404002248
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32519,0.00817584763655139,0.0133923848753192,-0.0180732267190743,0.0344249219921771,0.541557895701837
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32519,0.000336026163671984,0.0196683903137586,-0.0382140188512949,0.0388860711786388,0.986369563976091
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32519,-0.00349861827336828,0.0170171749158847,-0.0368522811085023,0.0298550445617658,0.837113747532909
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32519,-0.0390477731517425,0.0250340060489894,-0.0881144250077618,0.0100188787042768,0.118848923138633
ACTN2,Alpha-actinin-2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32519,0.00625536943808816,0.0133199193790389,-0.0198516725448282,0.0323624114210045,0.638635530096754
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32517,-0.0219252737645071,0.0147568270914149,-0.0508486548636804,0.00699810733466613,0.137378646228544
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32517,0.0141430531123662,0.020671142350433,-0.0263723858944824,0.0546584921192148,0.493872892975736
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32517,-0.0755198688014295,0.0435205782308704,-0.160820202133935,0.00978046453107652,0.0827315372245978
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32517,0.0160498343597067,0.0284905768975018,-0.0397916963593968,0.0718913650788102,0.57322017512045
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32517,-0.025241140439102,0.0398640394927603,-0.103374657844912,0.0528923769667081,0.526633600974814
ACTN2,Alpha-actinin-2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32517,0.0235957352028212,0.0209210105270045,-0.0174094454301076,0.06460091583575,0.259417359692405
ACTN2,Alpha-actinin-2,Mental health,X29171.Frequency of feeling 'in tune' with people,32428,0.0158092023388133,0.0455847016605052,-0.0735368129157769,0.105155217593403,0.728743676584548
ACTN2,Alpha-actinin-2,Mental health,X29172.Freuency of feeling that lacks companionship,32496,-0.0671806517631172,0.0410881053886765,-0.147713338324923,0.0133520347986888,0.10208001983402
ACTN2,Alpha-actinin-2,Mental health,X29173.Frequency of feeling left out,32445,-0.054389908440572,0.0425976354092268,-0.137881273842656,0.0291014569615125,0.20169962004264
ACTN2,Alpha-actinin-2,Mental health,X29174.Frequency of feeling isolated from others,32472,-0.00552850473586217,0.043989970048645,-0.0917488460312064,0.080691836559482,0.899991168386495
ACTN2,Alpha-actinin-2,Mental health,X29175.Tendency to bounce back quickly after hard times,32535,-0.0370194189101338,0.0370099610024017,-0.109558942474841,0.0355201046545736,0.317216805865059
ACTN2,Alpha-actinin-2,Mental health,X29176.Ability to make it through stressful events,32535,0.00956800792458152,0.0360699306503612,-0.0611290561501264,0.0802650719992895,0.790813847890716
ACTN2,Alpha-actinin-2,Mental health,X29177.Quick recovery from stressful events,32535,0.00541735106740297,0.0365184537617513,-0.0661588183056296,0.0769935204404355,0.882073750365398
ACTN2,Alpha-actinin-2,Mental health,X29178.Hard to snap back when something bad happens,32535,0.0316527984005362,0.0359276320948602,-0.0387653605053897,0.102070957306462,0.378335670967983
ACTN2,Alpha-actinin-2,Mental health,X29179.Comes through difficult times with little trouble,32535,-0.000356114838905767,0.036510242710675,-0.0719161905518287,0.0712039608740172,0.992217930812085
ACTN2,Alpha-actinin-2,Mental health,X29180.Tendency to take a long time to get over setbacks,32535,0.020341339516894,0.0362743457126458,-0.0507563780798917,0.0914390571136798,0.574974124646471
ACTN2,Alpha-actinin-2,Mental health,X29181.General happiness,32487,0.0252091161191554,0.0378856258250413,-0.0490467104979256,0.0994649427362364,0.505813444455914
ACTN2,Alpha-actinin-2,Mental health,X29182.Belief that own life is meaningful,32399,0.028560282048686,0.0373240100825629,-0.0445947777131373,0.101715341810509,0.444175996419904
ACTN2,Alpha-actinin-2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28840,-0.0519675886901061,0.0500824661132292,-0.150129222272035,0.0461940448918232,0.299494703687565
ACTN2,Alpha-actinin-2,Health and medical history,X2946.Father's age,29679,-0.00409702428510789,0.0121595875645614,-0.0279298159116483,0.0197357673414325,0.736177341479366
ACTN2,Alpha-actinin-2,Health and medical history,X2966.Age high blood pressure diagnosed,29407,-0.00351303832260629,0.00936009867001011,-0.0218588317158261,0.0148327550706135,0.707438074565324
ACTN2,Alpha-actinin-2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47060,0.0243008191231556,0.00392907188827844,0.0165998382221299,0.0320018000241814,6.32171684987058e-10
ACTN2,Alpha-actinin-2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47060,-0.0166013307114021,0.00462866541577382,-0.0256735149263188,-0.00752914649648546,0.000335679933842543
ACTN2,Alpha-actinin-2,Blood and urine assays,X30020.Haemoglobin concentration,47060,-0.0291597681021134,0.00503301434066897,-0.0390244762098246,-0.0192950599944022,6.97664771260026e-09
ACTN2,Alpha-actinin-2,Blood and urine assays,X30030.Haematocrit percentage,47060,-0.0241666414998273,0.00488715620199543,-0.0337454676557383,-0.0145878153439162,7.6717286293945e-07
ACTN2,Alpha-actinin-2,Blood and urine assays,X30040.Mean corpuscular volume,47060,-0.00468845332277157,0.00386674957132354,-0.0122672824825657,0.00289037583702256,0.225331786654737
ACTN2,Alpha-actinin-2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47059,-0.00682851071562913,0.00387818135837473,-0.0144297461780436,0.000772724746785338,0.0782941185387694
ACTN2,Alpha-actinin-2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47059,-0.0077949510486104,0.00379838642735392,-0.0152397884462241,-0.000350113650996723,0.0401642151518379
ACTN2,Alpha-actinin-2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47060,0.0164984122198802,0.00366419863997681,0.00931658288552561,0.0236802415542347,6.74631937966895e-06
ACTN2,Alpha-actinin-2,Blood and urine assays,X30080.Platelet count,47060,-0.0121741282904121,0.00388025369782324,-0.0197794255381456,-0.00456883104267855,0.00170639175771274
ACTN2,Alpha-actinin-2,Blood and urine assays,X30090.Platelet crit,47060,-0.0107941977780708,0.00398054724471879,-0.0185960703777196,-0.00299232517842195,0.00669822314068362
ACTN2,Alpha-actinin-2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47060,0.00609589567904928,0.00375284449738955,-0.00125967953583424,0.0134514708939328,0.104317191029564
ACTN2,Alpha-actinin-2,Blood and urine assays,X30110.Platelet distribution width,47060,0.0053128093819802,0.00375829922811829,-0.00205345710513165,0.012679075869092,0.15748708479943
ACTN2,Alpha-actinin-2,Blood and urine assays,X30120.Lymphocyte count,47028,0.011306917278831,0.00390441085002825,0.00365427201277566,0.0189595625448864,0.00378394233594053
ACTN2,Alpha-actinin-2,Blood and urine assays,X30130.Monocyte count,47028,0.0206823186903573,0.00396365732805152,0.0129135503273763,0.0284510870533383,1.82474766617964e-07
ACTN2,Alpha-actinin-2,Blood and urine assays,X30140.Neutrophill count,47028,0.0205232915064668,0.0039081745310478,0.0128632694256131,0.0281833135873205,1.52334998207088e-07
ACTN2,Alpha-actinin-2,Blood and urine assays,X30150.Eosinophill count,47028,0.00595806260204231,0.00384715894364912,-0.00158236892750998,0.0134984941315946,0.121469899873566
ACTN2,Alpha-actinin-2,Blood and urine assays,X30160.Basophill count,47028,0.0497135012860633,0.0243838389808381,0.00192117688362069,0.0975058256885059,0.0414827214835605
ACTN2,Alpha-actinin-2,Blood and urine assays,X30170.Nucleated red blood cell count,47028,0.134631349373824,0.0969032855041353,-0.0552990902142813,0.324561788961929,0.164743908412491
ACTN2,Alpha-actinin-2,Blood and urine assays,X30180.Lymphocyte percentage,47028,-0.00861611550528777,0.00386082164588278,-0.016183325931218,-0.00104890507935751,0.0256459459685684
ACTN2,Alpha-actinin-2,Blood and urine assays,X30190.Monocyte percentage,47028,0.00270135662104126,0.00391618266287443,-0.00497436139819261,0.0103770746402751,0.490331263450224
ACTN2,Alpha-actinin-2,Blood and urine assays,X30200.Neutrophill percentage,47028,0.00641308437670077,0.00382648692177224,-0.00108682998997281,0.0139129987433744,0.0937575530163962
ACTN2,Alpha-actinin-2,Blood and urine assays,X30210.Eosinophill percentage,47028,-0.00330821600651993,0.00380070839026833,-0.0107576044514459,0.004141172438406,0.384079685594822
ACTN2,Alpha-actinin-2,Blood and urine assays,X30220.Basophill percentage,47028,0.00482759260025988,0.00364293186485768,-0.00231255385486117,0.0119677390553809,0.185120121385509
ACTN2,Alpha-actinin-2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47028,0.13556022988386,0.0971968114341343,-0.0549455205270429,0.326065980294763,0.163120553899096
ACTN2,Alpha-actinin-2,Blood and urine assays,X30240.Reticulocyte percentage,46636,-0.00667656280163738,0.00400062621767717,-0.0145177901882846,0.00116466458500988,0.0951553879901694
ACTN2,Alpha-actinin-2,Blood and urine assays,X30250.Reticulocyte count,46636,-0.00996522730316946,0.00413326859355537,-0.018066433746538,-0.00186402085980094,0.0159178026322334
ACTN2,Alpha-actinin-2,Blood and urine assays,X30260.Mean reticulocyte volume,46636,0.00114004146332291,0.00381738822540082,-0.0063420394584627,0.00862212238510852,0.765214212012816
ACTN2,Alpha-actinin-2,Blood and urine assays,X30270.Mean sphered cell volume,46636,0.00300484957973316,0.00386369817624305,-0.00456799884570322,0.0105776980051696,0.436746324937538
ACTN2,Alpha-actinin-2,Blood and urine assays,X30280.Immature reticulocyte fraction,46636,-0.00351432143843263,0.00404582529741609,-0.0114441390213682,0.00441549614450291,0.385059449510247
ACTN2,Alpha-actinin-2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46636,-0.00695611256094332,0.00411261749295135,-0.015016842847128,0.00110461772524134,0.0907730238865507
ACTN2,Alpha-actinin-2,Blood and urine assays,X30300.High light scatter reticulocyte count,46636,-0.00954628570873192,0.00421532748711101,-0.0178083275834695,-0.00128424383399434,0.0235431266999708
ACTN2,Alpha-actinin-2,Blood and urine assays,X30500.Microalbumin in urine,30945,0.0319389767662138,0.00745286946149748,0.0173313526216787,0.0465466009107488,1.84996432783949e-05
ACTN2,Alpha-actinin-2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47112,0.00801767458138317,0.00400528854905271,0.000167309025239863,0.0158680401375265,0.0453211543956806
ACTN2,Alpha-actinin-2,Blood and urine assays,X30520.Potassium in urine,47071,-0.0134093935096054,0.00371558565607706,-0.0206919413955165,-0.00612684562369438,0.00030809241114225
ACTN2,Alpha-actinin-2,Blood and urine assays,X30530.Sodium in urine,47045,-0.0089006701365243,0.00391405842253745,-0.0165722246446977,-0.00122911562835091,0.0229737672640626
ACTN2,Alpha-actinin-2,Blood and urine assays,X30600.Albumin,44720,-0.00338228822418852,0.00415542765099414,-0.011526926420137,0.00476234997176,0.41568620610317
ACTN2,Alpha-actinin-2,Blood and urine assays,X30610.Alkaline phosphatase,46711,-0.0052516095909695,0.00392372634564897,-0.0129421132284415,0.00243889404650248,0.180771923614445
ACTN2,Alpha-actinin-2,Blood and urine assays,X30620.Alanine aminotransferase,46720,0.0445833625179352,0.0040824503087035,0.0365817599128763,0.052584965122994,1.07860267059811e-27
ACTN2,Alpha-actinin-2,Blood and urine assays,X30630.Apolipoprotein A,44523,-0.00457690891746962,0.00457425676274272,-0.0135424521724453,0.00438863433750611,0.317042062460169
ACTN2,Alpha-actinin-2,Blood and urine assays,X30640.Apolipoprotein B,46618,-0.0255338788891169,0.0039010873084094,-0.0331800100135993,-0.0178877477646345,6.06647563267857e-11
ACTN2,Alpha-actinin-2,Blood and urine assays,X30650.Aspartate aminotransferase,46655,0.103841409121049,0.00389028362854699,0.096216453209097,0.111466365033001,1.57450950561549e-154
ACTN2,Alpha-actinin-2,Blood and urine assays,X30660.Direct bilirubin,41750,-2.10858211518336e-06,0.00447702555432209,-0.00877707866858648,0.00877286150435611,0.999624219089789
ACTN2,Alpha-actinin-2,Blood and urine assays,X30670.Urea,46709,0.0525270697735377,0.00408904039056794,0.0445125506080245,0.0605415889390508,1.23538417463344e-37
ACTN2,Alpha-actinin-2,Blood and urine assays,X30680.Calcium,44723,0.0168228058498517,0.00398906343501525,0.00900424151722176,0.0246413701824815,2.48392430142393e-05
ACTN2,Alpha-actinin-2,Blood and urine assays,X30690.Cholesterol,46720,-0.0207596433485713,0.00401731845429073,-0.0286335875189811,-0.0128856991781614,2.39244784709301e-07
ACTN2,Alpha-actinin-2,Blood and urine assays,X30700.Creatinine,46715,0.0875165631320475,0.00451405526069087,0.0786690148210934,0.0963641114430017,4.7579610146369e-83
ACTN2,Alpha-actinin-2,Blood and urine assays,X30710.C-reactive protein,46660,-0.0083760351291159,0.00427851678712044,-0.016761928031872,9.85777364015568e-06,0.0502782014170797
ACTN2,Alpha-actinin-2,Blood and urine assays,X30720.Cystatin C,46720,0.0660275639561528,0.00441128585916979,0.0573814436721801,0.0746736842401256,2.09444771928176e-50
ACTN2,Alpha-actinin-2,Blood and urine assays,X30730.Gamma glutamyltransferase,46716,-0.00870819925412867,0.00402844254986103,-0.0166039466518563,-0.000812451856401051,0.0306535568436442
ACTN2,Alpha-actinin-2,Blood and urine assays,X30740.Glucose,44700,0.00101907115816434,0.0043027087535221,-0.00741423799873899,0.00945238031506766,0.81278013816916
ACTN2,Alpha-actinin-2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46627,0.0225204302358836,0.00436290627334854,0.0139691339401205,0.0310717265316468,2.4670214513e-07
ACTN2,Alpha-actinin-2,Blood and urine assays,X30760.HDL cholesterol,44711,0.00785774736918246,0.00479444987446475,-0.00153937438476845,0.0172548691231334,0.101244251410351
ACTN2,Alpha-actinin-2,Blood and urine assays,X30770.IGF-1,46592,0.0169601415410766,0.00392837341166257,0.00926052965421793,0.0246597534279352,1.58603423223676e-05
ACTN2,Alpha-actinin-2,Blood and urine assays,X30780.LDL direct,46670,-0.0245566839536706,0.00391227497292329,-0.0322247429006002,-0.0168886250067409,3.51935536836327e-10
ACTN2,Alpha-actinin-2,Blood and urine assays,X30790.Lipoprotein A,42265,0.00260194096512502,0.00429412210794789,-0.00581453836645283,0.0110184202967029,0.544568407831325
ACTN2,Alpha-actinin-2,Blood and urine assays,X30810.Phosphate,44681,0.0158405105171562,0.00429829370603321,0.00741585485333114,0.0242651661809813,0.00022902777288291
ACTN2,Alpha-actinin-2,Blood and urine assays,X30830.SHBG,44496,0.00215669879831948,0.00451789477518687,-0.00669837496104679,0.0110117725576857,0.633105237904865
ACTN2,Alpha-actinin-2,Blood and urine assays,X30840.Total bilirubin,46641,-0.000186419743555169,0.00394614920679549,-0.00792087218887433,0.00754803270176399,0.962321634655053
ACTN2,Alpha-actinin-2,Blood and urine assays,X30850.Testosterone,42891,-0.0222192991408415,0.00695166797985169,-0.0358445683813508,-0.00859402990033217,0.00139458979059645
ACTN2,Alpha-actinin-2,Blood and urine assays,X30860.Total protein,44719,-0.0020974694384606,0.00406876640433902,-0.0100722515909651,0.00587731271404387,0.60620579718346
ACTN2,Alpha-actinin-2,Blood and urine assays,X30870.Triglycerides,46714,-0.0165959681183422,0.00434303009491037,-0.0251083071043665,-0.00808362913231785,0.00013311740302813
ACTN2,Alpha-actinin-2,Blood and urine assays,X30880.Urate,46691,0.037122543000064,0.00480981866572077,0.0276952984152513,0.0465497875848767,1.2306005656333e-14
ACTN2,Alpha-actinin-2,Blood and urine assays,X30890.Vitamin D,45428,0.0197241484405677,0.0042975507336772,0.0113009490025603,0.028147347878575,4.46615130290223e-06
ACTN2,Alpha-actinin-2,Physical measures,X3137.Number of measurements made,45785,0.00992117931311966,0.0271348747512841,-0.0432631751993972,0.0631055338256365,0.714648797796654
ACTN2,Alpha-actinin-2,Physical measures,X3143.Ankle spacing width,37667,0.0159843775374635,0.00660182404934434,0.00304480240074856,0.0289239526741784,0.0154824769375366
ACTN2,Alpha-actinin-2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37666,-0.00144304080763416,0.00535818075867955,-0.0119450750946461,0.00905899347937775,0.787691156688276
ACTN2,Alpha-actinin-2,Physical measures,X3146.Speed of sound through heel,37667,-0.00748502781823262,0.00516418463352556,-0.0176068296999427,0.00263677406347747,0.147246470558115
ACTN2,Alpha-actinin-2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37667,-0.00566359561451567,0.0052307651712054,-0.0159158953500783,0.00458870412104692,0.278940464719327
ACTN2,Alpha-actinin-2,Physical measures,X3148.Heel bone mineral density (BMD),37665,-0.00590523171830814,0.00521788900192633,-0.0161322941620838,0.00432183072546747,0.257769293786976
ACTN2,Alpha-actinin-2,Health and medical history,X3526.Mother's age at death,38377,-0.00983683726669638,0.00490257579583296,-0.019445885826529,-0.000227788706863775,0.0448261643387805
ACTN2,Alpha-actinin-2,Health and medical history,X3581.Age at menopause (last menstrual period),37841,-0.00117781146113055,0.00498163068360844,-0.0109418076010031,0.00858618467874198,0.813101932279177
ACTN2,Alpha-actinin-2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29259,0.00907659621461167,0.00846651933242201,-0.00751778167693547,0.0256709741061588,0.28374798944357
ACTN2,Alpha-actinin-2,Physical measures,X4100.Ankle spacing width (left),32048,0.0184071618839084,0.0091657052684856,0.000442379557676668,0.0363719442101402,0.0446505107846769
ACTN2,Alpha-actinin-2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32048,0.00149487137486604,0.00745946387112037,-0.0131256778125299,0.016115420562262,0.841173667977137
ACTN2,Alpha-actinin-2,Physical measures,X4103.Speed of sound through heel (left),32048,-0.00523189166344244,0.00727723362191229,-0.0194952695623905,0.00903148623550566,0.472200230926052
ACTN2,Alpha-actinin-2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32048,-0.00294759297652049,0.00733931373771263,-0.0173326479024372,0.0114374619493963,0.68797723409009
ACTN2,Alpha-actinin-2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32046,-0.00327498824411134,0.00731975292938175,-0.0176217039856996,0.0110717274974769,0.654586138845842
ACTN2,Alpha-actinin-2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32048,-0.00292190804780887,0.00733882789105245,-0.0173060107142717,0.0114621946186539,0.690535457130885
ACTN2,Alpha-actinin-2,Physical measures,X4119.Ankle spacing width (right),32048,0.0117468253851937,0.00907775033207461,-0.0060455652656725,0.02953921603606,0.195696526249931
ACTN2,Alpha-actinin-2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32048,0.000686470738359342,0.00747813789314752,-0.0139706795322098,0.0153436210089285,0.926861736165533
ACTN2,Alpha-actinin-2,Physical measures,X4122.Speed of sound through heel (right),32048,-0.00281839098062529,0.00731025924790156,-0.0171464991065123,0.0115097171452618,0.699848818269796
ACTN2,Alpha-actinin-2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32048,-0.00167373557317906,0.00736141256748533,-0.0161021042054503,0.0127546330590922,0.820145207057688
ACTN2,Alpha-actinin-2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32045,-0.00184241610493388,0.0073508390224875,-0.0162500605890094,0.0125652283791416,0.80209904398139
ACTN2,Alpha-actinin-2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32048,-0.00167793785244405,0.00736141414835392,-0.0161063095832177,0.0127504338783296,0.819701437884414
ACTN2,Alpha-actinin-2,Physical measures,X4194.Pulse rate,32284,0.00181735883832755,0.00718986381187865,-0.0122747742329546,0.0159094919096097,0.800455061223887
ACTN2,Alpha-actinin-2,Physical measures,X4195.Pulse wave reflection index,32284,0.00122281721138863,0.00714340164206078,-0.0127782500070505,0.0152238844298278,0.864085585547509
ACTN2,Alpha-actinin-2,Physical measures,X4196.Pulse wave peak to peak time,32282,0.00174719068541028,0.00652512960494717,-0.0110420633402862,0.0145364447111067,0.788888521648338
ACTN2,Alpha-actinin-2,Physical measures,X4198.Position of the pulse wave peak,32284,9.08081913351624e-05,0.00630523478622382,-0.0122674519896635,0.0124490683723338,0.988509605321649
ACTN2,Alpha-actinin-2,Physical measures,X4199.Position of pulse wave notch,32284,0.0012022346052268,0.0070358737080229,-0.0125880778624981,0.0149925470729517,0.864328738955345
ACTN2,Alpha-actinin-2,Physical measures,X4200.Position of the shoulder on the pulse waveform,32284,-0.00253829527840619,0.00629446365415282,-0.0148754440405457,0.00979885348373334,0.686769156905975
ACTN2,Alpha-actinin-2,Physical measures,X4269.Number of triplets attempted (left),32196,-0.0315882952560133,0.115198963945509,-0.257378264589212,0.194201674077185,0.783933323304639
ACTN2,Alpha-actinin-2,Physical measures,X4270.Volume level set by participant (left),32122,0.0109339720388957,0.0356175672752847,-0.0588764598206623,0.0807444038984537,0.758864982624683
ACTN2,Alpha-actinin-2,Physical measures,X4276.Number of triplets attempted (right),32194,-0.0125634716820931,0.112869757129094,-0.233788195655118,0.208661252290932,0.911373844544506
ACTN2,Alpha-actinin-2,Physical measures,X4277.Volume level set by participant (right),32104,-0.0100414772545685,0.0355082195655119,-0.0796375876029717,0.0595546330938347,0.777343144265367
ACTN2,Alpha-actinin-2,Cognitive function,X4288.Time to answer,32341,0.00395341480175608,0.00810718187866568,-0.0119366616804286,0.0198434912839408,0.625815906568929
ACTN2,Alpha-actinin-2,Cognitive function,X4290.Duration screen displayed,32341,0.00445696914853645,0.00709126017200772,-0.00944190078859868,0.0183558390856716,0.529684287062066
ACTN2,Alpha-actinin-2,Physical measures,X46.Hand grip strength (left),47761,0.0230325595255589,0.00566202608934798,0.0119349883904369,0.0341301306606809,4.75946101153173e-05
ACTN2,Alpha-actinin-2,Physical measures,X47.Hand grip strength (right),47762,0.0189661461442868,0.00564974261307279,0.00789265062266411,0.0300396416659095,0.000789210721993829
ACTN2,Alpha-actinin-2,Physical measures,X48.Waist circumference,47835,0.014104768306605,0.00754537060558168,-0.000684158080335119,0.0288936946935451,0.0615897624011028
ACTN2,Alpha-actinin-2,Health and medical history,X4803.Tinnitus,32191,-0.00764448854643212,0.0435261913408348,-0.0929558235744683,0.077666846481604,0.860589525560924
ACTN2,Alpha-actinin-2,Working and living environment,X4825.Noisy workplace,32321,0.122331320467051,0.0594767011379619,0.0057569862366459,0.238905654697457,0.0397389491660649
ACTN2,Alpha-actinin-2,Working and living environment,X4836.Loud music exposure frequency,32270,0.10991967912023,0.067928510845175,-0.0232202021363131,0.243059560376773,0.105666948312223
ACTN2,Alpha-actinin-2,Physical measures,X49.Hip circumference,47833,0.00143059292171265,0.00639254208027736,-0.011098789555631,0.0139599753990563,0.822921944954518
ACTN2,Alpha-actinin-2,Physical measures,X50.Standing height,47830,0.042565197036466,0.00523116681603251,0.0323121100770422,0.0528182839958897,4.25740458765749e-16
ACTN2,Alpha-actinin-2,Health and medical history,X5057.Number of older siblings,31409,0.00379692568360473,0.0381082719908139,-0.0708952874183905,0.0784891387856,0.920636810515763
ACTN2,Alpha-actinin-2,Physical measures,X51.Seated height,47728,0.0160984603346716,0.00524600824903962,0.00581628416655392,0.0263806365027892,0.00215234728249596
ACTN2,Alpha-actinin-2,Eye measures,X5181.Ever had eye surgery,29792,-0.0692777434866912,0.0887144173745944,-0.243158001540896,0.104602514567514,0.434891598628682
ACTN2,Alpha-actinin-2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29778,0.00611993551880901,0.00838141981817008,-0.0103076473248044,0.0225475183624224,0.465312981113413
ACTN2,Alpha-actinin-2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29779,0.0186115266474185,0.00834252061793972,0.00226018623625659,0.0349628670585803,0.0257276543762088
ACTN2,Alpha-actinin-2,Eye measures,X5190.Duration at which refractometer first shown (right),29714,0.0203508768415237,0.00835083933402949,0.00398323174682593,0.0367185219362215,0.0148431788339706
ACTN2,Alpha-actinin-2,Eye measures,X5193.Duration at which refractometer first shown (left),29714,0.0196142775320284,0.00839667038200328,0.003156803583302,0.0360717514807549,0.019530741774802
ACTN2,Alpha-actinin-2,Eye measures,"X5199.logMAR, initial (right)",29760,0.0786251617702955,0.0450058452398305,-0.00958629489977229,0.166836618440363,0.0806953746033139
ACTN2,Alpha-actinin-2,Eye measures,X5200.Final number of letters displayed (right),29760,0.0653034466676926,0.348335632603551,-0.617434393235267,0.748041286570652,0.851297138118412
ACTN2,Alpha-actinin-2,Eye measures,"X5201.logMAR, final (right)",29717,0.0102982293576814,0.00873380407407824,-0.00682002662751196,0.0274164853428748,0.238402477651967
ACTN2,Alpha-actinin-2,Eye measures,X5202.Number of rounds to result (right),29760,0.0523786716793901,0.0412134096980495,-0.028399611328787,0.133156954687567,0.203815294319458
ACTN2,Alpha-actinin-2,Eye measures,"X5206.logMAR, initial (left)",29759,0.0185988680982712,0.044667372820273,-0.068949182629464,0.106146918826006,0.677144422806694
ACTN2,Alpha-actinin-2,Eye measures,X5207.Final number of letters displayed (left),29759,-0.125384692521756,0.250242308972955,-0.615859618108748,0.365090233065235,0.616354519328491
ACTN2,Alpha-actinin-2,Eye measures,"X5208.logMAR, final (left)",29704,-0.000447478381792526,0.00864448177281094,-0.017390662656502,0.0164957058929169,0.958718209248616
ACTN2,Alpha-actinin-2,Eye measures,X5209.Number of rounds to result (left),29757,0.0114022649193947,0.0422521516864516,-0.0714119523860503,0.0942164822248397,0.787276671933435
ACTN2,Alpha-actinin-2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29511,-0.00727961901526131,0.00850616093922952,-0.0239516944561512,0.00939245642562854,0.392145922444367
ACTN2,Alpha-actinin-2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29511,-0.0214837455236815,0.00853299763029297,-0.0382084208790558,-0.0047590701683073,0.011842167347652
ACTN2,Alpha-actinin-2,Eye measures,X5256.Corneal hysteresis (right),29511,-0.0165534566389094,0.00846845898872054,-0.0331516362568017,4.47229789828085e-05,0.0506712603075918
ACTN2,Alpha-actinin-2,Eye measures,X5257.Corneal resistance factor (right),29511,-0.0242848064103521,0.0084529513844047,-0.0408525911237853,-0.00771702169691887,0.00408366621809972
ACTN2,Alpha-actinin-2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29505,-0.00888991568510803,0.0085753520810176,-0.0256976057639025,0.00791777439368646,0.299933552297875
ACTN2,Alpha-actinin-2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29505,-0.0224543115893816,0.00848256686081187,-0.0390801426365729,-0.00582848054219034,0.0081434190593265
ACTN2,Alpha-actinin-2,Eye measures,X5264.Corneal hysteresis (left),29505,-0.0167770298194522,0.00868461441238248,-0.0337988740677218,0.000244814428817474,0.0534387378467249
ACTN2,Alpha-actinin-2,Eye measures,X5265.Corneal resistance factor (left),29505,-0.0239963946979119,0.00855614430677244,-0.0407664375391859,-0.00722635185663793,0.00505745606666939
ACTN2,Alpha-actinin-2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29102,0.100293658107269,0.17683220399283,-0.246297461718678,0.446884777933217,0.570627082263535
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47759,0.0319814316893211,0.0217421120612025,-0.0106331079506359,0.074595971329278,0.141319732351127
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47759,0.0135460271188033,0.0226602458291519,-0.0308680547063345,0.0579601089439411,0.549987086413576
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47759,0.00594328922784903,0.0580799666154999,-0.107893445338531,0.119780023794229,0.918496085362619
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47759,-0.00368842918882272,0.00956891531901218,-0.0224435032140866,0.0150666448364411,0.699900534440433
ACTN2,Alpha-actinin-2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47759,-0.0028045063438126,0.00874615809160186,-0.0199469762033522,0.0143379635157271,0.748474119030439
ACTN2,Alpha-actinin-2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35201,0.00706973643838592,0.0110390641827407,-0.0145668293597858,0.0287063022365576,0.521907409064347
ACTN2,Alpha-actinin-2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35201,-0.0079498149157857,0.0271818547653125,-0.0612262502557981,0.0453266204242267,0.76993468690791
ACTN2,Alpha-actinin-2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35201,0.00490302234418594,0.0215521795365981,-0.0373392495475464,0.0471452942359183,0.820042849355781
ACTN2,Alpha-actinin-2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35201,0.0171405616401389,0.01328019083631,-0.00888861239902875,0.0431697356793065,0.196840204200777
ACTN2,Alpha-actinin-2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47825,-0.0050611134015073,0.0177689434968428,-0.0398882426553192,0.0297660158523046,0.775777547708931
ACTN2,Alpha-actinin-2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47825,-0.0050611134015073,0.0177689434968428,-0.0398882426553192,0.0297660158523046,0.775777547708931
ACTN2,Alpha-actinin-2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47825,0.00380687990419072,0.014399909296298,-0.0244169423165533,0.0320307021249348,0.791498447279674
ACTN2,Alpha-actinin-2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47825,-0.0159363829074863,0.0222735411414084,-0.0595925235446467,0.0277197577296741,0.474316599888532
ACTN2,Alpha-actinin-2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47825,-0.0346411410049387,0.056742904476819,-0.145857233779504,0.0765749517696266,0.541541273020427
ACTN2,Alpha-actinin-2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47825,0.0284974707869008,0.0388585958448161,-0.0476653770689388,0.10466031864274,0.463344189682784
ACTN2,Alpha-actinin-2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47825,0.0207234108768209,0.0605252361994258,-0.0979060520740537,0.139352873827696,0.732058313045029
ACTN2,Alpha-actinin-2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47759,0.00479919815233975,0.0115916688811802,-0.0179204728547735,0.027518869159453,0.678862296492629
ACTN2,Alpha-actinin-2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47759,0.00785018134853901,0.0193408897437806,-0.030057962549271,0.045758325246349,0.684830662094165
ACTN2,Alpha-actinin-2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47759,-0.0227798729076559,0.0103157690546431,-0.0429987802547563,-0.00256096556055546,0.0272360360306676
ACTN2,Alpha-actinin-2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47759,0.0135270115005816,0.0191032214116094,-0.0239153024661728,0.0509693254673359,0.478889577063357
ACTN2,Alpha-actinin-2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47759,0.0188942072019048,0.0185174983634325,-0.0174000895904228,0.0551885039942324,0.307576218781551
ACTN2,Alpha-actinin-2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47759,0.0106655245060678,0.0103774678136984,-0.00967431240878107,0.0310053614209167,0.304074391175122
ACTN2,Alpha-actinin-2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30643,-1.27111933077635e-06,0.0400547118785302,-0.07850850640125,0.0785059641625885,0.999974680493575
ACTN2,Alpha-actinin-2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30643,0.00590672157302386,0.0263180028396878,-0.0456765639927642,0.0574900071388119,0.822425045166889
ACTN2,Alpha-actinin-2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30643,0.0452369449748009,0.0331562832035289,-0.0197493701041158,0.110223260053718,0.172505414894833
ACTN2,Alpha-actinin-2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30643,0.0332300185903856,0.0297466841385158,-0.0250734823211054,0.0915335195018765,0.263994953230305
ACTN2,Alpha-actinin-2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47745,0.042752569583399,0.0280287084001321,-0.01218369888086,0.097688838047658,0.127194478737621
ACTN2,Alpha-actinin-2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47745,0.0182114850608762,0.0501711785058413,-0.0801240248105728,0.116546994932325,0.716617896819859
ACTN2,Alpha-actinin-2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47745,0.0668868882572186,0.0819905378761111,-0.0938145659799592,0.227588342494396,0.414629799925666
ACTN2,Alpha-actinin-2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47745,0.0696841354054257,0.0744352541807042,-0.0762089627887546,0.215577233599606,0.349194794793055
ACTN2,Alpha-actinin-2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47745,-0.0116495809264617,0.0237103668467543,-0.0581218999461002,0.0348227380931768,0.623198696735602
ACTN2,Alpha-actinin-2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47745,0.0155439901075184,0.0341981234884744,-0.0514843319298914,0.0825723121449282,0.649453385649456
ACTN2,Alpha-actinin-2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47745,0.0449092833942436,0.0167306711998642,0.0121171678425098,0.0777013989459774,0.00727444064528546
ACTN2,Alpha-actinin-2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32456,0.0703451967888567,0.026162692644651,0.0190663192053408,0.121624074372373,0.00718665398187361
ACTN2,Alpha-actinin-2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32456,0.0360286446767353,0.0301120748084133,-0.0229910219477549,0.0950483113012254,0.231542803350804
ACTN2,Alpha-actinin-2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32456,0.0789591570439066,0.038967044128962,0.00258375055114096,0.155334563536672,0.0427665295653014
ACTN2,Alpha-actinin-2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32456,0.0442682682037193,0.0135771176585979,0.0176571175928675,0.0708794188145712,0.00111678859636294
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35427,0.0324755875794757,0.0133656924575452,0.00627883036268707,0.0586723447962644,0.0151242466331992
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35427,-0.017247500139547,0.0116681290841141,-0.0401170331444105,0.00562203286531662,0.139390479197478
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35427,-0.0192804609336612,0.0109503145856261,-0.0407430775214885,0.00218215565416603,0.0783132967634664
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35427,-0.0500311371177491,0.0261751908999828,-0.101334511281715,0.00127223704621707,0.0559798172345221
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35427,0.0156735554151663,0.0156453838510398,-0.0149913969328716,0.0463385077632043,0.31646197899869
ACTN2,Alpha-actinin-2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35427,-0.00408872219889537,0.0182824636669724,-0.0399223509861612,0.0317449065883704,0.8230402358151
ACTN2,Alpha-actinin-2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47759,0.0143657778994223,0.0254313203887435,-0.035479610062515,0.0642111658613596,0.572157250294771
ACTN2,Alpha-actinin-2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47759,0.0208623702299348,0.0161417660884399,-0.0107754913034075,0.0525002317632771,0.196215350683611
ACTN2,Alpha-actinin-2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47759,0.00160412147083368,0.0645806505406764,-0.124973953588892,0.128182196530559,0.98018356254214
ACTN2,Alpha-actinin-2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47759,0.0322337254810108,0.0160039042647559,0.000866073122089236,0.0636013778399323,0.0440087849917665
ACTN2,Alpha-actinin-2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47759,0.00851552650822479,0.0190269296990991,-0.0287772557020095,0.0458083087184591,0.654481239374183
ACTN2,Alpha-actinin-2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47759,0.00426650936644305,0.0214951924993908,-0.0378640679323629,0.046397086665249,0.842666037508606
ACTN2,Alpha-actinin-2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47759,-0.0184103475522454,0.00766080705476233,-0.0334255293795796,-0.00339516572491126,0.0162606626725444
ACTN2,Alpha-actinin-2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28141,0.0617024699013446,0.0251102626428277,0.0124863551214024,0.110918584681287,0.0140457857463109
ACTN2,Alpha-actinin-2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28141,0.0037989105497885,0.0337579912307089,-0.0623667522624009,0.0699645733619779,0.910406397926394
ACTN2,Alpha-actinin-2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28141,-0.0331101155573223,0.02221966609412,-0.0766606611017975,0.0104404299871529,0.136276418279126
ACTN2,Alpha-actinin-2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28141,0.00326774735635425,0.019989296238722,-0.0359112732715408,0.0424467679842493,0.870153519983875
ACTN2,Alpha-actinin-2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47860,-0.0252344638795308,0.00875165356884253,-0.0423877048744622,-0.00808122288459947,0.00393773587478322
ACTN2,Alpha-actinin-2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47860,-0.0376117201829605,0.0234957232449476,-0.0836633377430578,0.00843989737713685,0.109436920896977
ACTN2,Alpha-actinin-2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47860,-0.0148307139217916,0.00854115691966883,-0.0315713814843425,0.00190995364075931,0.0825094118036449
ACTN2,Alpha-actinin-2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47860,-0.0173802821613073,0.00850446248914908,-0.0340490286400395,-0.000711535682575148,0.0409977087307473
ACTN2,Alpha-actinin-2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47860,-0.0121426192577095,0.012255927810405,-0.0361642377661033,0.0118789992506844,0.321815568121559
ACTN2,Alpha-actinin-2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47860,-0.00936313830930609,0.0108463999807705,-0.0306220822716163,0.0118958056530042,0.388009707791158
ACTN2,Alpha-actinin-2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47860,-0.00102030278681982,0.00911324956532096,-0.0188822719348489,0.0168416663612093,0.910857529735316
ACTN2,Alpha-actinin-2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47860,0.0100168412352242,0.0247029224155501,-0.038400886699254,0.0584345691697023,0.68511949007921
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40611,0.0282797982143817,0.00929701845729733,0.0100576420380789,0.0465019543906844,0.0023553446518338
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40611,-0.034331640524783,0.0102777213156016,-0.0544759743033623,-0.0141873067462038,0.000838489856477524
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40611,0.0042279041688094,0.0103478910057308,-0.016053962202423,0.0245097705400418,0.682855958847504
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40611,0.0215034909210613,0.0131612878248011,-0.00429263321554873,0.0472996150576714,0.102311095348909
ACTN2,Alpha-actinin-2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40611,-0.0117960164881881,0.00936149793293489,-0.0301445524367405,0.00655251946036424,0.207667171375279
ACTN2,Alpha-actinin-2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47659,-0.022385382615692,0.00919997259475395,-0.0404173289014097,-0.00435343632997428,0.0149734888563322
ACTN2,Alpha-actinin-2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47659,0.00674845873778765,0.00743308466365167,-0.00782038720296961,0.0213173046785449,0.363943245193265
ACTN2,Alpha-actinin-2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47659,0.0184497987064504,0.0081074655649938,0.00255916619906254,0.0343404312138382,0.0228757092323056
ACTN2,Alpha-actinin-2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47659,0.0453156641363462,0.017918891991972,0.0101946358320812,0.0804366924406113,0.0114475786822095
ACTN2,Alpha-actinin-2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47670,0.00755347908135647,0.00840004617146501,-0.00891061141471495,0.0240175695774279,0.36854547658053
ACTN2,Alpha-actinin-2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47670,0.140648784098425,0.0152445451406705,0.110769475622711,0.170528092574139,3.0373214806522e-20
ACTN2,Alpha-actinin-2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47759,0.019885882178508,0.00800265862177572,0.00420067127982763,0.0355710930771885,0.0129654002749145
ACTN2,Alpha-actinin-2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47759,0.0154852535319098,0.00909198793455854,-0.00233504281982496,0.0333055498836445,0.0885485123353406
ACTN2,Alpha-actinin-2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47759,0.0293985298513149,0.0118651233912833,0.00614288800439969,0.0526541716982301,0.0132292794802374
ACTN2,Alpha-actinin-2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47759,0.0216240802871832,0.0173218460982635,-0.0123267380654133,0.0555748986397797,0.21190797638279
ACTN2,Alpha-actinin-2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47759,0.0210264770473723,0.0176800031196828,-0.013626329067206,0.0556792831619507,0.234341553182686
ACTN2,Alpha-actinin-2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47759,0.0416140775685969,0.0229642813620282,-0.00339591390097832,0.0866240690381721,0.069980223643017
ACTN2,Alpha-actinin-2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37667,-0.00566118551228937,0.0052307618897239,-0.0159134788161482,0.00459110779156946,0.279144775447812
ACTN2,Alpha-actinin-2,Physical activities,X864.Number of days or week walked 10+ minutes,47325,0.135880631154251,0.0222420751012103,0.0922861639558789,0.179475098352623,1.01767403450068e-09
ACTN2,Alpha-actinin-2,Physical activities,X874.Duration of walks,43888,0.0244917841767374,0.00412309340556245,0.016410521101835,0.0325730472516398,2.89616325796503e-09
ACTN2,Alpha-actinin-2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46409,0.170684584497303,0.021097779594348,0.129332936492381,0.212036232502225,6.26479267783071e-16
ACTN2,Alpha-actinin-2,Physical activities,X894.Duration of moderate activity,41249,0.116790605540251,0.0258549566147453,0.0661148905753504,0.167466320505152,6.31057314077611e-06
ACTN2,Alpha-actinin-2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29411,0.0349433760137464,0.00857748728993069,0.0181315009254823,0.0517552511020106,4.69647001722978e-05
ACTN2,Alpha-actinin-2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46419,0.154666736753009,0.021702639801341,0.11212956274238,0.197203910763637,1.06035912181449e-12
ACTN2,Alpha-actinin-2,Physical activities,X914.Duration of vigorous activity,35996,0.0152630312272078,0.00564877380077396,0.00419143457769084,0.0263346278767248,0.00690228525866051
